ID   NOL5_HUMAN              Reviewed;         529 AA.
AC   Q9Y2X3; Q53SA4; Q6PK08; Q9P036; Q9UFN3;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   10-JUN-2008, entry version 71.
DE   Nucleolar protein 5 (Nucleolar protein NOP5) (NOP58).
GN   Name=NOL5; Synonyms=NOP5; ORFNames=HSPC120;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Lyman S.K., Gerace L.;
RT   "Cloning and characterization of NOP5/NOP58.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=20384617; PubMed=10925205; DOI=10.1016/S0378-1119(00)00232-8;
RA   Nelson S.A., Santora K.E., LaRochelle W.J.;
RT   "Isolation and characterization of a novel PDGF-induced human gene.";
RL   Gene 253:87-93(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-442.
RC   TISSUE=Brain;
RG   The German cDNA consortium;
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 64-529.
RC   TISSUE=Umbilical cord blood;
RX   MEDLINE=20499367; PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [7]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
RX   MEDLINE=22317277; PubMed=12429849; DOI=10.1091/mbc.E02-05-0271;
RA   Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C.,
RA   Greco A., Hochstrasser D.F., Diaz J.-J.;
RT   "Functional proteomic analysis of human nucleolus.";
RL   Mol. Biol. Cell 13:4100-4109(2002).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-502 AND SER-514, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Epithelium;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-502, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Epithelium;
RX   PubMed=16565220; DOI=10.1073/pnas.0507066103;
RA   Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
RT   "Phosphoproteome analysis of the human mitotic spindle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109, AND MASS
RP   SPECTROMETRY.
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
CC   -!- FUNCTION: Required for 60S ribosomal subunit biogenesis (By
CC       similarity).
CC   -!- SUBUNIT: Interacts with NOLC1/Nopp140 (By similarity).
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- SIMILARITY: Belongs to the NOP5/NOP56 family.
CC   -!- SIMILARITY: Contains 1 Nop domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF123534; AAD27610.1; -; mRNA.
DR   EMBL; AF263608; AAF91394.1; -; mRNA.
DR   EMBL; AC064836; AAY24145.1; -; Genomic_DNA.
DR   EMBL; BC032592; AAH32592.1; -; mRNA.
DR   EMBL; BC009306; AAH09306.1; -; mRNA.
DR   EMBL; AL117554; CAB55989.2; -; mRNA.
DR   EMBL; AF161469; AAF29084.1; -; mRNA.
DR   PIR; T17299; T17299.
DR   RefSeq; NP_057018.1; -.
DR   UniGene; Hs.471104; -.
DR   IntAct; Q9Y2X3; -.
DR   PhosphoSite; Q9Y2X3; -.
DR   SWISS-2DPAGE; Q9Y2X3; -.
DR   PeptideAtlas; Q9Y2X3; -.
DR   Ensembl; ENSG00000055044; Homo sapiens.
DR   GeneID; 51602; -.
DR   KEGG; hsa:51602; -.
DR   NMPDR; fig|9606.3.peg.19174; -.
DR   H-InvDB; HIX0002748; -.
DR   HOGENOM; Q9Y2X3; -.
DR   HOVERGEN; Q9Y2X3; -.
DR   LinkHub; Q9Y2X3; -.
DR   ArrayExpress; Q9Y2X3; -.
DR   GermOnline; ENSG00000055044; Homo sapiens.
DR   GO; GO:0005730; C:nucleolus; TAS:UniProtKB.
DR   GO; GO:0016049; P:cell growth; TAS:UniProtKB.
DR   GO; GO:0006364; P:rRNA processing; TAS:UniProtKB.
DR   GO; GO:0006608; P:snRNP protein import into nucleus; ISS:UniProtKB.
DR   InterPro; IPR002687; Nop.
DR   InterPro; IPR012974; NOP5_N.
DR   InterPro; IPR012976; NOSIC.
DR   Pfam; PF01798; Nop; 1.
DR   Pfam; PF08156; NOP5NT; 1.
DR   Pfam; PF08060; NOSIC; 1.
DR   ProDom; PD004104; Nop; 1.
PE   1: Evidence at protein level;
KW   Nucleus; Phosphoprotein; Ribosome biogenesis.
FT   CHAIN         1    529       Nucleolar protein 5.
FT                                /FTId=PRO_0000219023.
FT   DOMAIN      253    401       Nop.
FT   COMPBIAS    441    524       Lys-rich.
FT   MOD_RES     109    109       Phosphoserine.
FT   MOD_RES     502    502       Phosphoserine.
FT   MOD_RES     514    514       Phosphoserine.
FT   CONFLICT      2      2       L -> M (in Ref. 5; CAB55989).
FT   CONFLICT    129    129       G -> V (in Ref. 5; CAB55989).
FT   CONFLICT    202    221       LTYCKCLQKVGDRKNYASAK -> YHTASVYRKLAIGRLCL
FT                                CQ (in Ref. 6; AAF29084).
FT   CONFLICT    235    260       KAAAEISMGTEVSEEDICNILHLCTQ -> EGSCRDIHGNR
FT                                GFRRRYLQYSASLHP (in Ref. 6; AAF29084).
FT   CONFLICT    280    280       M -> V (in Ref. 5; CAB55989).
SQ   SEQUENCE   529 AA;  59578 MW;  27CD73CFF5B9A556 CRC64;
     MLVLFETSVG YAIFKVLNEK KLQEVDSLWK EFETPEKANK IVKLKHFEKF QDTAEALAAF
     TALMEGKINK QLKKVLKKIV KEAHEPLAVA DAKLGGVIKE KLNLSCIHSP VVNELMRGIR
     SQMDGLIPGV EPREMAAMCL GLAHSLSRYR LKFSADKVDT MIVQAISLLD DLDKELNNYI
     MRCREWYGWH FPELGKIISD NLTYCKCLQK VGDRKNYASA KLSELLPEEV EAEVKAAAEI
     SMGTEVSEED ICNILHLCTQ VIEISEYRTQ LYEYLQNRMM AIAPNVTVMV GELVGARLIA
     HAGSLLNLAK HAASTVQILG AEKALFRALK SRRDTPKYGL IYHASLVGQT SPKHKGKISR
     MLAAKTVLAI RYDAFGEDSS SAMGVENRAK LEARLRTLED RGIRKISGTG KALAKTEKYE
     HKSEVKTYDP SGDSTLPTCS KKRKIEQVDK EDEITEKKAK KAKIKVKVEE EEEEKVAEEE
     ETSVKKKKKR GKKKHIKEEP LSEEEPCTST AIASPEKKKK KKKKRENED
//
ID   NPM_HUMAN               Reviewed;         294 AA.
AC   P06748; P08693; Q12826; Q13440; Q13441; Q14115; Q5EU94; Q5EU95;
AC   Q5EU96; Q5EU97; Q5EU98; Q5EU99; Q6V962; Q8WTW5; Q96AT6; Q96DC4;
AC   Q96EA5;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 2.
DT   01-JUL-2008, entry version 110.
DE   Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Numatrin)
DE   (Nucleolar protein NO38).
GN   Name=NPM1; Synonyms=NPM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   MEDLINE=89229105; PubMed=2713355; DOI=10.1021/bi00429a017;
RA   Chan W.-Y., Liu Q.R., Borjigin J., Busch H., Rennert O.M., Tease L.A.,
RA   Chan P.-K.;
RT   "Characterization of the cDNA encoding human nucleophosmin and studies
RT   of its role in normal and abnormal growth.";
RL   Biochemistry 28:1033-1039(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=B-cell lymphoma;
RX   MEDLINE=89374300; PubMed=2775293; DOI=10.1016/0006-291X(89)92100-1;
RA   Li X., McNeilage L.J., Whittingham S.;
RT   "The nucleotide sequence of a human cDNA encoding the highly conserved
RT   nucleolar phosphoprotein B23.";
RL   Biochem. Biophys. Res. Commun. 163:72-78(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Amnion;
RX   MEDLINE=90026373; PubMed=2478125; DOI=10.1016/0006-291X(89)91699-9;
RA   Zhang X.T., Thomis D.C., Samuel C.E.;
RT   "Isolation and characterization of a molecular cDNA clone of a human
RT   mRNA from interferon-treated cells encoding nucleolar protein B23,
RT   numatrin.";
RL   Biochem. Biophys. Res. Commun. 164:176-184(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   MEDLINE=97248692; PubMed=9092633; DOI=10.1093/nar/25.6.1225;
RA   Chan P.-K., Chan F.Y., Morris S.W., Xie Z.;
RT   "Isolation and characterization of the human nucleophosmin/B23 (NPM)
RT   gene: identification of the YY1 binding site at the 5' enhancer
RT   region.";
RL   Nucleic Acids Res. 25:1225-1232(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   INVOLVEMENT IN ACUTE MYELOGENOUS LEUKEMIA.
RC   TISSUE=Bone marrow;
RX   PubMed=15659725; DOI=10.1056/NEJMoa041974;
RA   Falini B., Mecucci C., Tiacci E., Alcalay M., Rosati R.,
RA   Pasqualucci L., La Starza R., Diverio D., Colombo E., Santucci A.,
RA   Bigerna B., Pacini R., Pucciarini A., Liso A., Vignetti M., Fazi P.,
RA   Meani N., Pettirossi V., Saglio G., Mandelli F., Lo-Coco F.,
RA   Pelicci P.-G., Martelli M.F.;
RT   "Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal
RT   karyotype.";
RL   N. Engl. J. Med. 352:254-266(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=16574551; DOI=10.1016/S1470-2045(06)70661-1;
RA   Bolli N., Galimberti S., Martelli M.P., Tabarrini A., Roti G.,
RA   Mecucci C., Martelli M.F., Petrini M., Falini B.;
RT   "Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after
RT   diagnosis of acute myeloid leukaemia.";
RL   Lancet Oncol. 7:350-352(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RA   Lu L., Huang X.Y., Yin L.L., Xu M., Li J.M., Zhou Z.M., Sha J.H.;
RT   "Cloning of a new transcript of nucleophosmin in testis.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Bone marrow, Brain, Kidney, Lung, Prostate, Testis, and
RC   Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-133, AND CHROMOSOMAL TRANSLOCATION
RP   WITH RARA.
RC   TISSUE=Bone marrow;
RX   MEDLINE=96151966; PubMed=8562957;
RA   Redner R.L., Rush E.A., Faas S., Rudert W.A., Corey S.J.;
RT   "The t(5;17) variant of acute promyelocytic leukemia expresses a
RT   nucleophosmin-retinoic acid receptor fusion.";
RL   Blood 87:882-886(1996).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-117, AND CHROMOSOMAL TRANSLOCATION
RP   WITH ALK.
RC   TISSUE=T-cell lymphoma;
RX   MEDLINE=94167588; PubMed=8122112;
RA   Morris S.W., Kirstein M.N., Valentine M.B., Dittmer K.G.,
RA   Shapiro D.N., Saltman D.L., Look A.T.;
RT   "Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in
RT   non-Hodgkin's lymphoma.";
RL   Science 263:1281-1284(1994).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-117, AND CHROMOSOMAL TRANSLOCATION
RP   WITH ALK.
RC   TISSUE=Lymphoma;
RX   MEDLINE=96210614; PubMed=8633037; DOI=10.1073/pnas.93.9.4181;
RA   Fujimoto J., Shiota M., Iwahara T., Seki N., Satoh H., Mori S.,
RA   Yamamoto T.;
RT   "Characterization of the transforming activity of p80, a
RT   hyperphosphorylated protein in a Ki-1 lymphoma cell line with
RT   chromosomal translocation t(2;5).";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:4181-4186(1996).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 15-294 (ISOFORM 1).
RC   TISSUE=Placenta;
RX   MEDLINE=90098787; PubMed=2602120;
RA   Hale T.K., Mansfield B.C.;
RT   "Nucleotide sequence of a cDNA clone representing a third allele of
RT   human protein B23.";
RL   Nucleic Acids Res. 17:10112-10112(1989).
RN   [14]
RP   PROTEIN SEQUENCE OF 33-54.
RC   TISSUE=Colon carcinoma;
RX   MEDLINE=97295306; PubMed=9150948;
RA   Ji H., Reid G.E., Moritz R.L., Eddes J.S., Burgess A.W., Simpson R.J.;
RT   "A two-dimensional gel database of human colon carcinoma proteins.";
RL   Electrophoresis 18:605-613(1997).
RN   [15]
RP   PROTEIN SEQUENCE OF 115-134.
RX   MEDLINE=86111864; PubMed=3944116;
RA   Chan P.-K., Aldrich M.B., Cook R.G., Busch H.;
RT   "Amino acid sequence of protein B23 phosphorylation site.";
RL   J. Biol. Chem. 261:1868-1872(1986).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 213-294 (ISOFORM 1), AND PROTEIN
RP   SEQUENCE OF 227-294.
RX   MEDLINE=87033628; PubMed=2429957;
RA   Chan P.-K., Chan W.-Y., Yung B.Y.M., Cook R.G., Aldrich M.B., Ku D.,
RA   Goldknopf I.L., Busch H.;
RT   "Amino acid sequence of a specific antigenic peptide of protein B23.";
RL   J. Biol. Chem. 261:14335-14341(1986).
RN   [17]
RP   CHROMOSOMAL TRANSLOCATION WITH MLF1.
RX   MEDLINE=96152893; PubMed=8570204;
RA   Yoneda-Kato N., Look A.T., Kirstein M.N., Valentine M.B.,
RA   Raimondi S.C., Cohen K.J., Carroll A.J., Morris S.W.;
RT   "The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid
RT   leukemia produces a novel fusion gene, NPM-MLF1.";
RL   Oncogene 12:265-275(1996).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE
RP   SCALE ANALYSIS].
RX   MEDLINE=22317277; PubMed=12429849; DOI=10.1091/mbc.E02-05-0271;
RA   Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C.,
RA   Greco A., Hochstrasser D.F., Diaz J.-J.;
RT   "Functional proteomic analysis of human nucleolus.";
RL   Mol. Biol. Cell 13:4100-4109(2002).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-199, AND MASS
RP   SPECTROMETRY.
RX   PubMed=16083285; DOI=10.1021/pr050048h;
RA   Kim J.-E., Tannenbaum S.R., White F.M.;
RT   "Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
RL   J. Proteome Res. 4:1339-1346(2005).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-10; SER-70;
RP   THR-95; THR-199 AND SER-254, AND MASS SPECTROMETRY.
RC   TISSUE=Epithelium;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-150; LYS-154 AND LYS-212,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Epithelium;
RX   PubMed=16916647; DOI=10.1016/j.molcel.2006.06.026;
RA   Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,
RA   Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
RT   "Substrate and functional diversity of lysine acetylation revealed by
RT   a proteomics survey.";
RL   Mol. Cell 23:607-618(2006).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-125 AND SER-254,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Epithelium;
RX   PubMed=16565220; DOI=10.1073/pnas.0507066103;
RA   Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
RT   "Phosphoproteome analysis of the human mitotic spindle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; THR-75; THR-95;
RP   SER-137; THR-199; SER-254 AND SER-260, AND MASS SPECTROMETRY.
RC   TISSUE=Epithelium;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [24]
RP   INTERACTION WITH NSUN2.
RX   PubMed=17215513; DOI=10.1091/mbc.E06-11-1021;
RA   Sakita-Suto S., Kanda A., Suzuki F., Sato S., Takata T., Tatsuka M.;
RT   "Aurora-B regulates RNA methyltransferase NSUN2.";
RL   Mol. Biol. Cell 18:1107-1117(2007).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-125; SER-137;
RP   THR-199; THR-234; THR-237 AND SER-260, AND MASS SPECTROMETRY.
RX   PubMed=17287340; DOI=10.1073/pnas.0611217104;
RA   Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
RT   "Global proteomic profiling of phosphopeptides using electron transfer
RT   dissociation tandem mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-88; SER-125 AND
RP   THR-279, AND MASS SPECTROMETRY.
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
CC   -!- FUNCTION: Associated with nucleolar ribonucleoprotein structures
CC       and bind single-stranded nucleic acids. It may function in the
CC       assembly and/or transport of ribosome.
CC   -!- SUBUNIT: Disulfide-linked dimers under certain conditions. The
CC       SWAP complex consists of NPM1, NCL, PARP1 and SWAP70 (By
CC       similarity). Interacts with NSUN2.
CC   -!- INTERACTION:
CC       Q98147:- (xeno); NbExp=2; IntAct=EBI-78579, EBI-626601;
CC       Q9NX58:LYAR; NbExp=1; IntAct=EBI-78579, EBI-713507;
CC       Q00987:MDM2; NbExp=3; IntAct=EBI-78579, EBI-389668;
CC       P55345:PRMT2; NbExp=1; IntAct=EBI-78579, EBI-78458;
CC       P04637:TP53; NbExp=3; IntAct=EBI-78579, EBI-366083;
CC       P04637:TP53; NbExp=1; IntAct=EBI-354150, EBI-366083;
CC       Q15853:USF2; NbExp=1; IntAct=EBI-78579, EBI-1055994;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus. Note=Generally
CC       nucleolar, but is translocated to the nucleoplasm in case of serum
CC       starvation or treatment with anticancer drugs. Has been found in
CC       the cytoplasm in patients with primary acute myelogenous leukemia
CC       (AML), but not with secondary AML.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P06748-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P06748-2; Sequence=VSP_003616;
CC   -!- PTM: Phosphorylated.
CC   -!- DISEASE: A chromosomal aberration involving NPM1 is found in a
CC       form of non-Hodgkin lymphoma. Translocation t(2;5)(p23;q35) with
CC       ALK. The resulting chimeric NPM1-ALK protein homodimerize and the
CC       kinase becomes constitutively activated.
CC   -!- DISEASE: A chromosomal aberration involving NPM1 is found in a
CC       form of acute promyelocytic leukemia. Translocation
CC       t(5;17)(q32;q11) with RARA.
CC   -!- DISEASE: A chromosomal aberration involving NPM1 is a cause of
CC       myelodysplastic syndrome (MDS). Translocation t(3;5)(q25.1;q34)
CC       with MLF1.
CC   -!- DISEASE: Defects in NPM1 are associated with acute myelogenous
CC       leukemia (AML). Mutations in exon 12 affecting the C-terminus of
CC       the protein are associated with an aberrant cytoplasmic location.
CC   -!- SIMILARITY: Belongs to the nucleoplasmin family.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NPM1.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M23613; AAA36380.1; -; mRNA.
DR   EMBL; M28699; AAA58386.1; -; mRNA.
DR   EMBL; M26697; AAA36385.1; -; mRNA.
DR   EMBL; U89321; AAB94739.1; -; Genomic_DNA.
DR   EMBL; U89309; AAB94739.1; JOINED; Genomic_DNA.
DR   EMBL; U89310; AAB94739.1; JOINED; Genomic_DNA.
DR   EMBL; U89311; AAB94739.1; JOINED; Genomic_DNA.
DR   EMBL; U89313; AAB94739.1; JOINED; Genomic_DNA.
DR   EMBL; U89314; AAB94739.1; JOINED; Genomic_DNA.
DR   EMBL; U89317; AAB94739.1; JOINED; Genomic_DNA.
DR   EMBL; U89319; AAB94739.1; JOINED; Genomic_DNA.
DR   EMBL; AY740634; AAW67752.1; -; mRNA.
DR   EMBL; AY740635; AAW67753.1; -; mRNA.
DR   EMBL; AY740636; AAW67754.1; -; mRNA.
DR   EMBL; AY740637; AAW67755.1; -; mRNA.
DR   EMBL; AY740638; AAW67756.1; -; mRNA.
DR   EMBL; AY740639; AAW67757.1; -; mRNA.
DR   EMBL; AY740640; AAW67758.1; -; mRNA.
DR   EMBL; DQ303464; ABC40399.1; -; mRNA.
DR   EMBL; AY347529; AAQ24860.1; -; mRNA.
DR   EMBL; BT007011; AAP35657.1; -; mRNA.
DR   EMBL; BC002398; AAH02398.1; -; mRNA.
DR   EMBL; BC008495; AAH08495.1; -; mRNA.
DR   EMBL; BC009623; AAH09623.1; -; mRNA.
DR   EMBL; BC012566; AAH12566.1; -; mRNA.
DR   EMBL; BC014349; AAH14349.1; -; mRNA.
DR   EMBL; BC016716; AAH16716.1; -; mRNA.
DR   EMBL; BC016768; AAH16768.1; -; mRNA.
DR   EMBL; BC016824; AAH16824.1; -; mRNA.
DR   EMBL; BC021668; AAH21668.1; -; mRNA.
DR   EMBL; BC021983; AAH21983.1; -; mRNA.
DR   EMBL; BC050628; AAH50628.1; -; mRNA.
DR   EMBL; U41742; AAB00112.1; ALT_TERM; mRNA.
DR   EMBL; U41743; AAB00113.1; ALT_TERM; mRNA.
DR   EMBL; U04946; AAA58698.1; ALT_TERM; mRNA.
DR   EMBL; D45915; BAA08343.1; ALT_TERM; mRNA.
DR   EMBL; X16934; CAA34809.1; -; mRNA.
DR   EMBL; J02590; AAA36473.1; -; mRNA.
DR   EMBL; M31004; AAA36474.1; -; mRNA.
DR   PIR; A33423; A32915.
DR   PIR; I38491; I38491.
DR   RefSeq; NP_002511.1; -.
DR   RefSeq; NP_954654.1; -.
DR   UniGene; Hs.557550; -.
DR   UniGene; Hs.654469; -.
DR   UniGene; Hs.654583; -.
DR   PDB; 2P1B; X-ray; 2.75 A; A/B/C/D/E/F/G/H/I/J=9-124.
DR   PDBsum; 2P1B; -.
DR   IntAct; P06748; -.
DR   PhosphoSite; P06748; -.
DR   SWISS-2DPAGE; P06748; -.
DR   DOSAC-COBS-2DPAGE; P06748; -.
DR   REPRODUCTION-2DPAGE; IPI00549248; -.
DR   Ensembl; ENSG00000181163; Homo sapiens.
DR   GeneID; 4869; -.
DR   H-InvDB; HIX0005411; -.
DR   HGNC; HGNC:7910; NPM1.
DR   MIM; 164040; gene.
DR   PharmGKB; PA31712; -.
DR   HOVERGEN; P06748; -.
DR   Reactome; REACT_6185; HIV Infection.
DR   LinkHub; P06748; -.
DR   ArrayExpress; P06748; -.
DR   GermOnline; ENSG00000181163; Homo sapiens.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0051059; F:NF-kappaB binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IMP:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; TAS:UniProtKB.
DR   GO; GO:0030957; F:Tat protein binding; IDA:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0006916; P:anti-apoptosis; TAS:UniProtKB.
DR   GO; GO:0007569; P:cell aging; IMP:UniProtKB.
DR   GO; GO:0007098; P:centrosome cycle; IMP:UniProtKB.
DR   GO; GO:0006886; P:intracellular protein transport; TAS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0006913; P:nucleocytoplasmic transport; TAS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcript...; IMP:UniProtKB.
DR   GO; GO:0006950; P:response to stress; IMP:UniProtKB.
DR   GO; GO:0042255; P:ribosome assembly; TAS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:UniProtKB.
DR   InterPro; IPR004301; Nucleoplasmin.
DR   PANTHER; PTHR22747; Nucleoplasmin; 1.
DR   Pfam; PF03066; Nucleoplasmin; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Chromosomal rearrangement; Direct protein sequencing; Nucleus;
KW   Phosphoprotein; Proto-oncogene; RNA-binding.
FT   CHAIN         1    294       Nucleophosmin.
FT                                /FTId=PRO_0000219481.
FT   MOTIF       152    157       Nuclear localization signal (Potential).
FT   MOTIF       191    197       Nuclear localization signal (Potential).
FT   COMPBIAS      1      9       Met-rich.
FT   COMPBIAS    120    132       Asp/Glu-rich (acidic).
FT   COMPBIAS    161    188       Asp/Glu-rich (highly acidic).
FT   SITE        175    176       Breakpoint for translocation to form
FT                                NPM1-MLF1.
FT   MOD_RES       4      4       Phosphoserine.
FT   MOD_RES      10     10       Phosphoserine.
FT   MOD_RES      70     70       Phosphoserine.
FT   MOD_RES      75     75       Phosphothreonine.
FT   MOD_RES      88     88       Phosphoserine.
FT   MOD_RES      95     95       Phosphothreonine.
FT   MOD_RES     106    106       Phosphoserine (By similarity).
FT   MOD_RES     125    125       Phosphoserine.
FT   MOD_RES     137    137       Phosphoserine.
FT   MOD_RES     150    150       N6-acetyllysine.
FT   MOD_RES     154    154       N6-acetyllysine.
FT   MOD_RES     199    199       Phosphothreonine.
FT   MOD_RES     212    212       N6-acetyllysine.
FT   MOD_RES     234    234       Phosphothreonine.
FT   MOD_RES     237    237       Phosphothreonine.
FT   MOD_RES     254    254       Phosphoserine.
FT   MOD_RES     260    260       Phosphoserine.
FT   MOD_RES     279    279       Phosphothreonine.
FT   VAR_SEQ     195    223       Missing (in isoform 2).
FT                                /FTId=VSP_003616.
FT   CONFLICT     80     80       K -> E (in Ref. 9; AAH21983).
FT   CONFLICT    129    129       E -> D (in Ref. 15; AA sequence).
FT   CONFLICT    168    168       Missing (in Ref. 5; AAW67758).
FT   CONFLICT    178    178       D -> G (in Ref. 9; AAH16768).
FT   CONFLICT    213    213       D -> P (in Ref. 16; AAA36473/AAA36474).
FT   CONFLICT    216    216       P -> S (in Ref. 16; AAA36473).
FT   CONFLICT    219    221       TPR -> SSS (in Ref. 16; AAA36473).
FT   CONFLICT    231    231       Q -> R (in Ref. 7; AAQ24860).
FT   CONFLICT    271    271       Y -> C (in Ref. 9; AAH16768).
FT   CONFLICT    287    287       L -> F (in Ref. 9; AAH12566).
FT   CONFLICT    288    294       WQWRKSL -> CLAVEEVSLRK (in Ref. 5;
FT                                AAW67752/AAW67755).
FT   CONFLICT    288    294       WQWRKSL -> CMAVEEVSLRK (in Ref. 5;
FT                                AAW67753 and 6).
FT   CONFLICT    288    294       WQWRKSL -> CVAVEEVSLRK (in Ref. 5;
FT                                AAW67754).
FT   CONFLICT    290    294       WRKSL -> SLAQVSLRK (in Ref. 5; AAW67756).
FT   CONFLICT    290    294       WRKSL -> SLEKVSLRK (in Ref. 5; AAW67757).
SQ   SEQUENCE   294 AA;  32575 MW;  620BC7BA2E4A0054 CRC64;
     MEDSMDMDMS PLRPQNYLFG CELKADKDYH FKVDNDENEH QLSLRTVSLG AGAKDELHIV
     EAEAMNYEGS PIKVTLATLK MSVQPTVSLG GFEITPPVVL RLKCGSGPVH ISGQHLVAVE
     EDAESEDEEE EDVKLLSISG KRSAPGGGSK VPQKKVKLAA DEDDDDDDEE DDDEDDDDDD
     FDDEEAEEKA PVKKSIRDTP AKNAQKSNQN GKDSKPSSTP RSKGQESFKK QEKTPKTPKG
     PSSVEDIKAK MQASIEKGGS LPKVEAKFIN YVKNCFRMTD QEAIQDLWQW RKSL
//
ID   CH60_STAAN              Reviewed;         538 AA.
AC   P99083; Q99SL7;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   10-JUN-2008, entry version 24.
DE   60 kDa chaperonin (Protein Cpn60) (groEL protein).
GN   Name=groL; Synonyms=groEL; OrderedLocusNames=SA1836;
OS   Staphylococcus aureus (strain N315).
OC   Bacteria; Firmicutes; Bacillales; Staphylococcus.
OX   NCBI_TaxID=158879;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=21311952; PubMed=11418146; DOI=10.1016/S0140-6736(00)04403-2;
RA   Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I.,
RA   Cui L., Oguchi A., Aoki K., Nagai Y., Lian J.-Q., Ito T., Kanamori M.,
RA   Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y.,
RA   Takahashi N.K., Sawano T., Inoue R., Kaito C., Sekimizu K.,
RA   Hirakawa H., Kuhara S., Goto S., Yabuzaki J., Kanehisa M.,
RA   Yamashita A., Oshima K., Furuya K., Yoshino C., Shiba T., Hattori M.,
RA   Ogasawara N., Hayashi H., Hiramatsu K.;
RT   "Whole genome sequencing of meticillin-resistant Staphylococcus
RT   aureus.";
RL   Lancet 357:1225-1240(2001).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15590099; DOI=10.1016/j.mimet.2004.09.017;
RA   Scherl A., Francois P., Bento M., Deshusses J.M., Charbonnier Y.,
RA   Converset V., Huyghe A., Walter N., Hoogland C., Appel R.D.,
RA   Sanchez J.-C., Zimmermann-Ivol C.G., Corthals G.L., Hochstrasser D.F.,
RA   Schrenzel J.;
RT   "Correlation of proteomic and transcriptomic profiles of
RT   Staphylococcus aureus during the post-exponential phase of growth.";
RL   J. Microbiol. Methods 60:247-257(2005).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RA   Vaezzadeh A.R., Deshusses J., Lescuye P., Hochstrasser D.F.;
RT   "Shotgun proteomic analysis of total and membrane protein extracts of
RT   S. aureus strain N315.";
RL   Submitted (OCT-2007) to UniProtKB.
CC   -!- FUNCTION: Prevents misfolding and promotes the refolding and
CC       proper assembly of unfolded polypeptides generated under stress
CC       conditions (By similarity).
CC   -!- SUBUNIT: Oligomer of 14 subunits composed of two stacked rings of
CC       7 subunits (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity).
CC   -!- SIMILARITY: Belongs to the chaperonin (HSP60) family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000018; BAB43116.1; -; Genomic_DNA.
DR   PIR; C89994; C89994.
DR   RefSeq; NP_375137.1; -.
DR   HSSP; Q9Z462; 1IOK.
DR   SWISS-2DPAGE; P99083; -.
DR   GeneID; 1124728; -.
DR   GenomeReviews; BA000018_GR; SA1836.
DR   KEGG; sau:SA1836; -.
DR   HOGENOM; P99083; -.
DR   BioCyc; SAUR158879:SA1836-MON; -.
DR   GO; GO:0005524; F:ATP binding; IEA:HAMAP.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:HAMAP.
DR   GO; GO:0042026; P:protein refolding; IEA:HAMAP.
DR   HAMAP; MF_00600; -; 1.
DR   InterPro; IPR001844; Chaprnin_Cpn60.
DR   InterPro; IPR002423; Cpn60/TCP-1.
DR   InterPro; IPR012723; GroEL.
DR   PANTHER; PTHR11353; Cpn60/TCP-1; 1.
DR   Pfam; PF00118; Cpn60_TCP1; 1.
DR   PRINTS; PR00298; CHAPERONIN60.
DR   PRINTS; PR00304; TCOMPLEXTCP1.
DR   TIGRFAMs; TIGR02348; GroEL; 1.
DR   PROSITE; PS00296; CHAPERONINS_CPN60; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Chaperone; Complete proteome; Cytoplasm;
KW   Nucleotide-binding.
FT   CHAIN         1    538       60 kDa chaperonin.
FT                                /FTId=PRO_0000063533.
SQ   SEQUENCE   538 AA;  57572 MW;  A3D8595603DC9313 CRC64;
     MVKQLKFSED ARQAMLRGVD QLANAVKVTI GPKGRNVVLD KEFTAPLITN DGVTIAKEIE
     LEDPYENMGA KLVQEVANKT NEIAGDGTTT ATVLAQAMIQ EGLKNVTSGA NPVGLRQGID
     KAVKVAVEAL HENSQKVENK NEIAQVGAIS AADEEIGRYI SEAMEKVGND GVITIEESNG
     LNTELEVVEG MQFDRGYQSP YMVTDSDKMV AELERPYILV TDKKISSFQD ILPLLEQVVQ
     SNRPILIVAD EVEGDALTNI VLNRMRGTFT AVAVKAPGFG DRRKAMLEDL AILTGAQVIT
     DDLGLDLKDA SIDMLGTASK VEVTKDNTTV VDGDGDENSI DARVSQLKSQ IEETESDFDR
     EKLQERLAKL AGGVAVIKVG AASETELKER KLRIEDALNS TRAAVEEGIV AGGGTALVNV
     YQKVSEIEAE GDIETGVNIV LKALTAPVRQ IAENAGLEGS VIVERLKNAE PGVGFNAATN
     EWVNMLEAGI VDPTKVTRSA LQHAASVAAM FLTTEAVVAS IPEKNNDQPN MGGMPGMM
//
ID   TIG_STAAM               Reviewed;         433 AA.
AC   P66934; Q99TI6;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   10-JUN-2008, entry version 23.
DE   Trigger factor (TF).
GN   Name=tig; OrderedLocusNames=SAV1675;
OS   Staphylococcus aureus (strain Mu50 / ATCC 700699).
OC   Bacteria; Firmicutes; Bacillales; Staphylococcus.
OX   NCBI_TaxID=158878;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=21311952; PubMed=11418146; DOI=10.1016/S0140-6736(00)04403-2;
RA   Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I.,
RA   Cui L., Oguchi A., Aoki K., Nagai Y., Lian J.-Q., Ito T., Kanamori M.,
RA   Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y.,
RA   Takahashi N.K., Sawano T., Inoue R., Kaito C., Sekimizu K.,
RA   Hirakawa H., Kuhara S., Goto S., Yabuzaki J., Kanehisa M.,
RA   Yamashita A., Oshima K., Furuya K., Yoshino C., Shiba T., Hattori M.,
RA   Ogasawara N., Hayashi H., Hiramatsu K.;
RT   "Whole genome sequencing of meticillin-resistant Staphylococcus
RT   aureus.";
RL   Lancet 357:1225-1240(2001).
CC   -!- FUNCTION: Involved in protein export. Acts as a chaperone by
CC       maintaining the newly synthesized protein in an open conformation
CC       (By similarity).
CC   -!- SIMILARITY: Belongs to the FKBP-type PPIase family. Tig subfamily.
CC   -!- SIMILARITY: Contains 1 PPIase FKBP-type domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000017; BAB57837.1; -; Genomic_DNA.
DR   RefSeq; NP_372199.1; -.
DR   HSSP; P47480; 1HXV.
DR   World-2DPAGE; 0002:P66934; -.
DR   GeneID; 1121650; -.
DR   GenomeReviews; BA000017_GR; SAV1675.
DR   KEGG; sav:SAV1675; -.
DR   HOGENOM; P66934; -.
DR   BioCyc; SAUR158878:SAV1675-MON; -.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:HAMAP.
DR   GO; GO:0006457; P:protein folding; IEA:HAMAP.
DR   GO; GO:0015031; P:protein transport; IEA:HAMAP.
DR   HAMAP; MF_00303; -; 1.
DR   InterPro; IPR001179; PPIase_FKBP.
DR   InterPro; IPR005215; Trig_fac.
DR   InterPro; IPR008880; Trigger_fac_C_bac.
DR   InterPro; IPR008881; Trigger_fac_ribosome-bd_bac.
DR   Gene3D; G3DSA:3.30.70.1050; Trigger_fac_ribosome-bd_bac; 1.
DR   Pfam; PF00254; FKBP_C; 1.
DR   Pfam; PF05698; Trigger_C; 1.
DR   Pfam; PF05697; Trigger_N; 1.
DR   PIRSF; PIRSF003095; Trigger_factor; 1.
DR   TIGRFAMs; TIGR00115; tig; 1.
DR   PROSITE; PS50059; FKBP_PPIASE; 1.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Chaperone; Complete proteome; Isomerase;
KW   Rotamase.
FT   CHAIN         1    433       Trigger factor.
FT                                /FTId=PRO_0000179426.
FT   DOMAIN      163    248       PPIase FKBP-type.
SQ   SEQUENCE   433 AA;  48609 MW;  8865D9AF6A1BC1E7 CRC64;
     MTATWEKKEG NEGLLTVTVP AEKVNKALDQ AFKKVVKQIN VPGFRKGKVP RPIFEQRFGV
     EALYQDAIDI LLPDAYGEAI DETDIKPVAQ PEVSVTQIEK GKDFIFEATV TVEPEVKLGD
     YKGLEIEKQE TELSDDELQE AIDHSLGHLA EMVVKEDGVV ENGDTVNIDF SGSVDGEEFE
     GGQAEGYDLE IGSGSFIPGF EEQLEGMKVD EEKDVVVTFP EEYHAEELAG KEATFKTKVN
     EIKFKEVPEL TDEIANELDA EANTVDEYKE NLRKRLAEQK ATDAENVEKE EAITKATDNT
     TIDIPEAMVN TELDRMVSEF AQRIQQQGLD LQTYFQISGQ DETQLREQMK DDAEQRVKTN
     LTLTAIAEAE KIEATDEDID KELEKMSKQF NISVEDIKNT LGNTDIIKND VRIQKVIDLL
     RDNAKFVEGT KED
//
ID   ODP2_STAAN              Reviewed;         430 AA.
AC   P65636; Q99V06;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   10-JUN-2008, entry version 27.
DE   Dihydrolipoyllysine-residue acetyltransferase component of pyruvate
DE   dehydrogenase complex (EC 2.3.1.12) (E2) (Dihydrolipoamide
DE   acetyltransferase component of pyruvate dehydrogenase complex).
GN   Name=pdhC; OrderedLocusNames=SA0945;
OS   Staphylococcus aureus (strain N315).
OC   Bacteria; Firmicutes; Bacillales; Staphylococcus.
OX   NCBI_TaxID=158879;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=21311952; PubMed=11418146; DOI=10.1016/S0140-6736(00)04403-2;
RA   Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I.,
RA   Cui L., Oguchi A., Aoki K., Nagai Y., Lian J.-Q., Ito T., Kanamori M.,
RA   Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y.,
RA   Takahashi N.K., Sawano T., Inoue R., Kaito C., Sekimizu K.,
RA   Hirakawa H., Kuhara S., Goto S., Yabuzaki J., Kanehisa M.,
RA   Yamashita A., Oshima K., Furuya K., Yoshino C., Shiba T., Hattori M.,
RA   Ogasawara N., Hayashi H., Hiramatsu K.;
RT   "Whole genome sequencing of meticillin-resistant Staphylococcus
RT   aureus.";
RL   Lancet 357:1225-1240(2001).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RA   Vaezzadeh A.R., Deshusses J., Lescuye P., Hochstrasser D.F.;
RT   "Shotgun proteomic analysis of total and membrane protein extracts of
RT   S. aureus strain N315.";
RL   Submitted (OCT-2007) to UniProtKB.
CC   -!- FUNCTION: The pyruvate dehydrogenase complex catalyzes the overall
CC       conversion of pyruvate to acetyl-CoA and CO(2). It contains
CC       multiple copies of three enzymatic components: pyruvate
CC       dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and
CC       lipoamide dehydrogenase (E3).
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + enzyme N(6)-(dihydrolipoyl)lysine
CC       = CoA + enzyme N(6)-(S-acetyldihydrolipoyl)lysine.
CC   -!- COFACTOR: Binds 1 lipoyl cofactor covalently (By similarity).
CC   -!- SUBUNIT: Forms a 24-polypeptide structural core with octahedral
CC       symmetry (By similarity).
CC   -!- SIMILARITY: Belongs to the 2-oxoacid dehydrogenase family.
CC   -!- SIMILARITY: Contains 1 lipoyl-binding domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000018; BAB42191.1; -; Genomic_DNA.
DR   PIR; D89879; D89879.
DR   RefSeq; NP_374213.1; -.
DR   HSSP; P11961; 2PDE.
DR   SMR; P65636; 2-79, 121-165.
DR   SWISS-2DPAGE; P99131; -.
DR   GeneID; 1123770; -.
DR   GenomeReviews; BA000018_GR; SA0945.
DR   KEGG; sau:SA0945; -.
DR   HOGENOM; P65636; -.
DR   BioCyc; SAUR158879:SA0945-MON; -.
DR   GO; GO:0004742; F:dihydrolipoyllysine-residue acetyltransfera...; IEA:EC.
DR   InterPro; IPR003016; 2-oxoA_DHase_lipoyl-BS.
DR   InterPro; IPR001078; 2Oxoacid_DHase.
DR   InterPro; IPR000089; Biotin_lipoyl.
DR   InterPro; IPR004167; E3_bd.
DR   Gene3D; G3DSA:4.10.320.10; E3_bd; 1.
DR   Pfam; PF00198; 2-oxoacid_dh; 1.
DR   Pfam; PF00364; Biotin_lipoyl; 1.
DR   Pfam; PF02817; E3_binding; 1.
DR   ProDom; PD001115; 2Oxoacid_dh; 1.
DR   PROSITE; PS50968; BIOTINYL_LIPOYL; 1.
DR   PROSITE; PS00189; LIPOYL; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Complete proteome; Glycolysis; Lipoyl; Transferase.
FT   CHAIN         1    430       Dihydrolipoyllysine-residue
FT                                acetyltransferase component of pyruvate
FT                                dehydrogenase complex.
FT                                /FTId=PRO_0000162289.
FT   DOMAIN        1     76       Lipoyl-binding.
FT   ACT_SITE    401    401       Potential.
FT   BINDING      43     43       Lipoyl (covalent) (By similarity).
SQ   SEQUENCE   430 AA;  46368 MW;  4050074CAE5ACDA4 CRC64;
     MAFEFRLPDI GEGIHEGEIV KWFVKAGDTI EEDDVLAEVQ NDKSVVEIPS PVSGTVEEVM
     VEEGTVAVVG DVIVKIDAPD AEDMQFKGHD DDSSSKEEPA KEEAPAEQAP VATQTEEVDE
     NRTVKAMPSV RKYAREKGVN IKAVSGSGKN GRITKEDVDA YLNGGAPTAS NESAASATSE
     EVAETPAAPA AVSLEGDFPE TTEKIPAMRR AIAKAMVNSK HTAPHVTLMD EIDVQALWDH
     RKKFKEIAAE QGTKLTFLPY VVKALVSALK KYPALNTSFN EEAGEIVHKH YWNIGIAADT
     DRGLLVPVVK HADRKSIFQI SDEINELAVK ARDGKLTADE MKGATCTISN IGSAGGQWFT
     PVINHPEVAI LGIGRIAQKP IVKDGEIVAA PVLALSLSFD HRQIDGATGQ NAMNHIKRLL
     NNPELLLMEG
//
ID   TKT_STAAS               Reviewed;         662 AA.
AC   Q6G9L6;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   10-JUN-2008, entry version 29.
DE   Transketolase (EC 2.2.1.1) (TK).
GN   Name=tkt; OrderedLocusNames=SAS1282;
OS   Staphylococcus aureus (strain MSSA476).
OC   Bacteria; Firmicutes; Bacillales; Staphylococcus.
OX   NCBI_TaxID=282459;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15213324; DOI=10.1073/pnas.0402521101;
RA   Holden M.T.G., Feil E.J., Lindsay J.A., Peacock S.J., Day N.P.J.,
RA   Enright M.C., Foster T.J., Moore C.E., Hurst L., Atkin R., Barron A.,
RA   Bason N., Bentley S.D., Chillingworth C., Chillingworth T.,
RA   Churcher C., Clark L., Corton C., Cronin A., Doggett J., Dowd L.,
RA   Feltwell T., Hance Z., Harris B., Hauser H., Holroyd S., Jagels K.,
RA   James K.D., Lennard N., Line A., Mayes R., Moule S., Mungall K.,
RA   Ormond D., Quail M.A., Rabbinowitsch E., Rutherford K.M., Sanders M.,
RA   Sharp S., Simmonds M., Stevens K., Whitehead S., Barrell B.G.,
RA   Spratt B.G., Parkhill J.;
RT   "Complete genomes of two clinical Staphylococcus aureus strains:
RT   evidence for the rapid evolution of virulence and drug resistance.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:9786-9791(2004).
CC   -!- CATALYTIC ACTIVITY: Sedoheptulose 7-phosphate + D-glyceraldehyde
CC       3-phosphate = D-ribose 5-phosphate + D-xylulose 5-phosphate.
CC   -!- COFACTOR: Binds 1 calcium ion per subunit (By similarity).
CC   -!- COFACTOR: Binds 1 thiamine pyrophosphate per subunit (By
CC       similarity).
CC   -!- PATHWAY: Carbohydrate biosynthesis; Calvin cycle.
CC   -!- PATHWAY: Carbohydrate degradation; pentose phosphate pathway.
CC   -!- SIMILARITY: Belongs to the transketolase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX571857; CAG43060.1; -; Genomic_DNA.
DR   RefSeq; YP_043407.1; -.
DR   GeneID; 2864103; -.
DR   GenomeReviews; BX571857_GR; SAS1282.
DR   KEGG; sas:SAS1282; -.
DR   HOGENOM; Q6G9L6; -.
DR   BioCyc; SAUR282459:SAS1282-MON; -.
DR   InterPro; IPR005478; BacTransketolase.
DR   InterPro; IPR005476; Transketo_C.
DR   InterPro; IPR005475; Transketo_Cen_R.
DR   InterPro; IPR005474; Transketo_N.
DR   InterPro; IPR015941; Transketolase_C-like.
DR   Gene3D; G3DSA:3.40.50.920; Transketo_C_like; 1.
DR   PANTHER; PTHR11624:SF1; BacTransketolase; 1.
DR   Pfam; PF02779; Transket_pyr; 1.
DR   Pfam; PF02780; Transketolase_C; 1.
DR   Pfam; PF00456; Transketolase_N; 1.
DR   TIGRFAMs; TIGR00232; tktlase_bact; 1.
DR   PROSITE; PS00801; TRANSKETOLASE_1; 1.
DR   PROSITE; PS00802; TRANSKETOLASE_2; 1.
PE   3: Inferred from homology;
KW   Calcium; Complete proteome; DNA recombination; Metal-binding;
KW   Thiamine pyrophosphate; Transferase.
FT   CHAIN         1    662       Transketolase.
FT                                /FTId=PRO_0000191874.
FT   METAL       156    156       Calcium (By similarity).
FT   METAL       186    186       Calcium (By similarity).
FT   METAL       188    188       Calcium (via carbonyl oxygen) (By
FT                                similarity).
SQ   SEQUENCE   662 AA;  72251 MW;  3723932E63AFAC9C CRC64;
     MFNEKDQLAV DTLRALSIDT IEKANSGHPG LPMGAAPMAY TLWTRHLNFN PQSKDYFNRD
     RFVLSAGHGS ALLYSLLHVS GSLELEELKQ FRQWGSKTPG HPEYRHTDGV EVTTGPLGQG
     FAMSVGLALA EDHLAGKFNK EGYNVVDHYT YVLASDGDLM EGISHEAASF AGHNKLSKLV
     VLYDSNDISL DGELNKAFSE NTKARFEAYG WNYLLVKDGN DLEEIDKAIT TAKSQEGPTI
     IEVKTTIGFG SPNKAGTNGV HGAPLGEVER KLTFENYGLD PEKRFNVSEE VYEIFQNTML
     KRANEDESQW NSLLEKYAET YPELAEEFKL AISGKLPKNY KDELPRFELG HNGASRADSG
     TVIQAISKTV PSFFGGSADL AGSNKSNVND ATDYSSETPE GKNVWFGVRE FAMGAAVNGM
     AAHGGLHPYG ATFFVFSDYL KPALRLSSIM GLNATFIFTH DSIAVGEDGP THEPIEQLAG
     LRAIPNMNVI RPADGNETRV AWEVALESES TPTSLVLTRQ NLPVLDVPED VVEEGVRKGA
     YTVYGSEETP EFLLLASGSE VSLAVEAAKD LEKQGKSVRV VSMPNWNAFE QQSEEYKESV
     IPSSVTKRVA IEMASPLGWH KYVGTAGKVI AIDGFGASAP GDLVVEKYGF TKENILNQVM
     SL
//
ID   PT1_STAAN               Reviewed;         572 AA.
AC   Q99V14;
DT   02-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   10-JUN-2008, entry version 45.
DE   Phosphoenolpyruvate-protein phosphotransferase (EC 2.7.3.9)
DE   (Phosphotransferase system, enzyme I).
GN   Name=ptsI; OrderedLocusNames=SA0935;
OS   Staphylococcus aureus (strain N315).
OC   Bacteria; Firmicutes; Bacillales; Staphylococcus.
OX   NCBI_TaxID=158879;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=21311952; PubMed=11418146; DOI=10.1016/S0140-6736(00)04403-2;
RA   Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I.,
RA   Cui L., Oguchi A., Aoki K., Nagai Y., Lian J.-Q., Ito T., Kanamori M.,
RA   Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y.,
RA   Takahashi N.K., Sawano T., Inoue R., Kaito C., Sekimizu K.,
RA   Hirakawa H., Kuhara S., Goto S., Yabuzaki J., Kanehisa M.,
RA   Yamashita A., Oshima K., Furuya K., Yoshino C., Shiba T., Hattori M.,
RA   Ogasawara N., Hayashi H., Hiramatsu K.;
RT   "Whole genome sequencing of meticillin-resistant Staphylococcus
RT   aureus.";
RL   Lancet 357:1225-1240(2001).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15590099; DOI=10.1016/j.mimet.2004.09.017;
RA   Scherl A., Francois P., Bento M., Deshusses J.M., Charbonnier Y.,
RA   Converset V., Huyghe A., Walter N., Hoogland C., Appel R.D.,
RA   Sanchez J.-C., Zimmermann-Ivol C.G., Corthals G.L., Hochstrasser D.F.,
RA   Schrenzel J.;
RT   "Correlation of proteomic and transcriptomic profiles of
RT   Staphylococcus aureus during the post-exponential phase of growth.";
RL   J. Microbiol. Methods 60:247-257(2005).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RA   Vaezzadeh A.R., Deshusses J., Lescuye P., Hochstrasser D.F.;
RT   "Shotgun proteomic analysis of total and membrane protein extracts of
RT   S. aureus strain N315.";
RL   Submitted (OCT-2007) to UniProtKB.
CC   -!- FUNCTION: General (non sugar-specific) component of the
CC       phosphoenolpyruvate-dependent sugar phosphotransferase system
CC       (sugar PTS). This major carbohydrate active-transport system
CC       catalyzes the phosphorylation of incoming sugar substrates
CC       concomitantly with their translocation across the cell membrane.
CC       Enzyme I transfers the phosphoryl group from phosphoenolpyruvate
CC       (PEP) to the phosphoryl carrier protein (HPr).
CC   -!- CATALYTIC ACTIVITY: Phosphoenolpyruvate + protein L-histidine =
CC       pyruvate + protein N(pi)-phospho-L-histidine.
CC   -!- COFACTOR: Magnesium (By similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- DOMAIN: The N-terminal domain contains the HPr binding site, the
CC       central domain the pyrophosphate/phosphate carrier histidine, and
CC       the C-terminal domain the pyruvate binding site (By similarity).
CC   -!- MISCELLANEOUS: The reaction takes place in three steps, mediated
CC       by a phosphocarrier histidine residue located on the surface of
CC       the central domain. The two first partial reactions are catalyzed
CC       at an active site located on the N-terminal domain, and the third
CC       partial reaction is catalyzed at an active site located on the C-
CC       terminal domain. For catalytic turnover, the central domain
CC       swivels from the concave surface of the N-terminal domain to that
CC       of the C-terminal domain (By similarity).
CC   -!- SIMILARITY: Belongs to the PEP-utilizing enzyme family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000018; BAB42181.1; -; Genomic_DNA.
DR   PIR; B89878; B89878.
DR   RefSeq; NP_374203.1; -.
DR   HSSP; P08839; 1EZC.
DR   SWISS-2DPAGE; Q99V14; -.
DR   GeneID; 1123759; -.
DR   GenomeReviews; BA000018_GR; SA0935.
DR   KEGG; sau:SA0935; -.
DR   HOGENOM; Q99V14; -.
DR   BioCyc; SAUR158879:SA0935-MON; -.
DR   InterPro; IPR008279; PEP_mobile.
DR   InterPro; IPR006318; PEP_P_trans.
DR   InterPro; IPR000121; PEP_utilizers.
DR   InterPro; IPR008731; PTS_PEP_utilis_N.
DR   InterPro; IPR015813; Pyrv/PenolPyrv_Kinase_cat.
DR   Gene3D; G3DSA:3.50.30.10; PEP_mobile; 1.
DR   Gene3D; G3DSA:1.10.274.10; PTS_PEP_utilis_N; 1.
DR   Gene3D; G3DSA:3.20.20.60; Pyrv/PenolPyrv_Kinase_cat; 1.
DR   Pfam; PF05524; PEP-utilisers_N; 1.
DR   Pfam; PF00391; PEP-utilizers; 1.
DR   Pfam; PF02896; PEP-utilizers_C; 1.
DR   PRINTS; PR01736; PHPHTRNFRASE.
DR   ProDom; PD000940; PEP_utilizers; 1.
DR   TIGRFAMs; TIGR01417; PTS_I_fam; 1.
DR   PROSITE; PS00742; PEP_ENZYMES_2; 1.
DR   PROSITE; PS00370; PEP_ENZYMES_PHOS_SITE; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Kinase; Magnesium; Metal-binding;
KW   Phosphotransferase system; Sugar transport; Transferase; Transport.
FT   CHAIN         1    572       Phosphoenolpyruvate-protein
FT                                phosphotransferase.
FT                                /FTId=PRO_0000147082.
FT   ACT_SITE    191    191       Tele-phosphohistidine intermediate (By
FT                                similarity).
FT   ACT_SITE    504    504       Proton donor (By similarity).
FT   METAL       433    433       Magnesium (By similarity).
FT   METAL       457    457       Magnesium (By similarity).
FT   BINDING     298    298       Substrate (By similarity).
FT   BINDING     334    334       Substrate (By similarity).
FT   BINDING     433    433       Substrate (By similarity).
FT   BINDING     454    454       Substrate; via carbonyl oxygen (By
FT                                similarity).
FT   BINDING     455    455       Substrate; via amide nitrogen (By
FT                                similarity).
FT   BINDING     456    456       Substrate (By similarity).
FT   BINDING     457    457       Substrate; via amide nitrogen (By
FT                                similarity).
SQ   SEQUENCE   572 AA;  63224 MW;  88D6B3F829BCC926 CRC64;
     MSKLIKGIAA SDGVAIAKAY LLVEPDLTFD KNEKVTDVEG EVAKFNSAIE ASKVELTKIR
     NNAEVQLGAD KAAIFDAHLL VLDDPELIQP IQDKIKNENA NAATALTDVT TQFVTIFESM
     DNEYMKERAA DIRDVSKRVL SHILGVELPN PSMIDESVVI VGNDLTPSDT AQLNKEFVQG
     FATNIGGRTS HSAIMSRSLE IPAIVGTKSI TQEVKQGDMI IVDGLNGDVI VNPTEDELIA
     YQDKRECYFA DKKELQKLRD ADTVTVDGVH AELAANIGTP NDLPGVIENG AQGIGLYRTE
     FLYMGRDQMP TEEEQFEAYK EVLEAMDGKR VVVRTLDIGG DKELSYLNLP EEMNPFLGYR
     AIRLCLAQQD IFRPQLRALL RASVYGKLNI MFPMVATINE FREAKAILLE EKENLKNEGH
     DISDDIELGI MVEIPATAAL ADVFAKEVDF FSIGTNDLIQ YTLAADRMSE RVSYLYQPYN
     PSILRLVKQV IEASHKEGKW TGMCGEMAGD ETAIPLLLGL GLDEFSMSAT SILKARRQIN
     GLSKNEMTEL ANRAVDCATQ EEVIELVNNY VK
//
ID   DNAK_STAAS              Reviewed;         610 AA.
AC   Q6G8Y7;
DT   21-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   10-JUN-2008, entry version 22.
DE   Chaperone protein dnaK (Heat shock protein 70) (Heat shock 70 kDa
DE   protein) (HSP70).
GN   Name=dnaK; OrderedLocusNames=SAS1518;
OS   Staphylococcus aureus (strain MSSA476).
OC   Bacteria; Firmicutes; Bacillales; Staphylococcus.
OX   NCBI_TaxID=282459;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15213324; DOI=10.1073/pnas.0402521101;
RA   Holden M.T.G., Feil E.J., Lindsay J.A., Peacock S.J., Day N.P.J.,
RA   Enright M.C., Foster T.J., Moore C.E., Hurst L., Atkin R., Barron A.,
RA   Bason N., Bentley S.D., Chillingworth C., Chillingworth T.,
RA   Churcher C., Clark L., Corton C., Cronin A., Doggett J., Dowd L.,
RA   Feltwell T., Hance Z., Harris B., Hauser H., Holroyd S., Jagels K.,
RA   James K.D., Lennard N., Line A., Mayes R., Moule S., Mungall K.,
RA   Ormond D., Quail M.A., Rabbinowitsch E., Rutherford K.M., Sanders M.,
RA   Sharp S., Simmonds M., Stevens K., Whitehead S., Barrell B.G.,
RA   Spratt B.G., Parkhill J.;
RT   "Complete genomes of two clinical Staphylococcus aureus strains:
RT   evidence for the rapid evolution of virulence and drug resistance.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:9786-9791(2004).
CC   -!- FUNCTION: Acts as a chaperone (By similarity).
CC   -!- INDUCTION: By stress conditions e.g. heat shock (By similarity).
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX571857; CAG43319.1; -; Genomic_DNA.
DR   RefSeq; YP_043636.1; -.
DR   GeneID; 2863734; -.
DR   GenomeReviews; BX571857_GR; SAS1518.
DR   KEGG; sas:SAS1518; -.
DR   HOGENOM; Q6G8Y7; -.
DR   BioCyc; SAUR282459:SAS1518-MON; -.
DR   GO; GO:0005524; F:ATP binding; IEA:HAMAP.
DR   HAMAP; MF_00332; -; 1.
DR   InterPro; IPR012725; DnaK_prok.
DR   InterPro; IPR001023; Hsp70.
DR   InterPro; IPR013126; Hsp_70.
DR   PANTHER; PTHR19375; Hsp70; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   ProDom; PD000089; Hsp70; 1.
DR   TIGRFAMs; TIGR02350; prok_dnaK; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Chaperone; Complete proteome; Nucleotide-binding;
KW   Phosphoprotein; Stress response.
FT   CHAIN         1    610       Chaperone protein dnaK.
FT                                /FTId=PRO_0000078540.
FT   MOD_RES     173    173       Phosphothreonine; by autocatalysis (By
FT                                similarity).
SQ   SEQUENCE   610 AA;  66361 MW;  B71645C36D26AAED CRC64;
     MSKIIGIDLG TTNSCVTVLE GDEPKVIQNP EGSRTTPSVV AFKNGETQVG EVAKRQAITN
     PNTVQSIKRH MGTDYKVDIE GKSYTPQEIS AMILQNLKNT AESYLGEKVD KAVITVPAYF
     NDAERQATKD AGKIAGLEVE RIINEPTAAA LAYGLDKTDK DEKVLVFDLG GGTFDVSILE
     LGDGVFEVLS TAGDNKLGGD DFDQVIIDYL VAEFKKENGV DLSQDKMALQ RLKDAAEKAK
     KDLSGVSQTQ ISLPFISAGE NGPLHLEVNL TRSKFEELSD SLIRRTMEPT RQAMKDAGLT
     NSDIDEVILV GGSTRIPAVQ EAVKKEIGKE PNKGVNPDEV VAMGAAIQGG VITGDVKDVV
     LLDVTPLSLG IEILGGRMNT LIERNTTIPT SKSQIYSTAV DNQPSVDVHV LQGERPMAAD
     NKTLGRFQLT DIPPAERGKP QIEVTFDIDK NGIVNVTAKD LGTNKEQRIT IQSSSSLSDE
     EIDRMVKDAE VNAEADKKRR EEVDLRNEAD SLVFQVEKTL TDLGENIGEE DKKSAEEKKD
     ALKTALEGQD IEDIKSKKEE LEKVIQELSA KVYEQAAQQQ QQAQGANAGQ NNDSTVEDAE
     FKEVKDDDKK
//
ID   MYG_HORSE               Reviewed;         154 AA.
AC   P68082; P02188;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-JUN-2008, entry version 32.
DE   Myoglobin.
GN   Name=MB;
OS   Equus caballus (Horse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus.
OX   NCBI_TaxID=9796;
RN   [1]
RP   PROTEIN SEQUENCE OF 2-154.
RC   TISSUE=Heart muscle;
RX   MEDLINE=70064092; PubMed=4902609;
RA   Dautrevaux M., Boulanger Y., Han K., Biserte G.;
RT   "Covalent structure of horse myoglobin.";
RL   Eur. J. Biochem. 11:267-277(1969).
RN   [2]
RP   PROTEIN SEQUENCE OF 2-154.
RC   TISSUE=Skeletal muscle;
RA   Romero-Herrera A.E., Lehmann H.;
RT   "Residue 122 of sperm whale and horse myoglobin.";
RL   Biochim. Biophys. Acta 336:318-323(1974).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-16 AND 57-71.
RX   MEDLINE=90147691; PubMed=2302197; DOI=10.1016/0006-291X(90)91922-F;
RA   Jahnen W., Ward L.D., Reid G.E., Moritz R.L., Simpson R.J.;
RT   "Internal amino acid sequencing of proteins by in situ cyanogen
RT   bromide cleavage in polyacrylamide gels.";
RL   Biochem. Biophys. Res. Commun. 166:139-145(1990).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS).
RX   MEDLINE=90294302; PubMed=2359126; DOI=10.1016/S0022-2836(05)80270-0;
RA   Evans S.V., Brayer G.D.;
RT   "High-resolution study of the three-dimensional structure of horse
RT   heart metmyoglobin.";
RL   J. Mol. Biol. 213:885-897(1990).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS).
RX   MEDLINE=88153746; PubMed=3346247;
RA   Evans S.V., Brayer G.D.;
RT   "Horse heart metmyoglobin. A 2.8-A resolution three-dimensional
RT   structure determination.";
RL   J. Biol. Chem. 263:4263-4268(1988).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF MUTANT THR-65.
RX   MEDLINE=95383313; PubMed=7654702; DOI=10.1021/bi00033a021;
RA   Bogumil R., Maurus R., Hildebrand D.P., Brayer G.D., Mauk A.G.;
RT   "Origin of the pH-dependent spectroscopic properties of
RT   pentacoordinate metmyoglobin variants.";
RL   Biochemistry 34:10483-10490(1995).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS).
RX   MEDLINE=20168811; PubMed=10706294; DOI=10.1038/35002641;
RA   Chu K., Vojtchovsky J., McMahon B.H., Sweet R.M., Berendzen J.,
RA   Schlichting I.;
RT   "Structure of a ligand-binding intermediate in wild-type carbonmonoxy
RT   myoglobin.";
RL   Nature 403:921-923(2000).
CC   -!- FUNCTION: Serves as a reserve supply of oxygen and facilitates the
CC       movement of oxygen within muscles.
CC   -!- SIMILARITY: Belongs to the globin family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   PIR; A91098; MYHO.
DR   RefSeq; XP_001500028.1; -.
DR   PDB; 1AZI; X-ray; 2.00 A; A=1-154.
DR   PDB; 1BJE; X-ray; 1.80 A; A=1-154.
DR   PDB; 1DWR; X-ray; 1.45 A; A=1-154.
DR   PDB; 1DWS; X-ray; 1.45 A; A=1-154.
DR   PDB; 1DWT; X-ray; 1.40 A; A=1-154.
DR   PDB; 1GJN; X-ray; 1.35 A; A=1-154.
DR   PDB; 1HRM; X-ray; 1.70 A; A=1-154.
DR   PDB; 1HSY; X-ray; 1.90 A; A=1-154.
DR   PDB; 1NPF; X-ray; 1.90 A; A=1-154.
DR   PDB; 1NPG; X-ray; 1.70 A; A=1-154.
DR   PDB; 1NZ2; X-ray; 1.90 A; A=1-154.
DR   PDB; 1NZ3; X-ray; 1.60 A; A=1-154.
DR   PDB; 1NZ4; X-ray; 1.80 A; A=1-154.
DR   PDB; 1NZ5; X-ray; 1.70 A; A=1-154.
DR   PDB; 1RSE; X-ray; 1.70 A; A=1-154.
DR   PDB; 1WLA; X-ray; 1.70 A; A=1-154.
DR   PDB; 1XCH; X-ray; 1.70 A; A=1-154.
DR   PDB; 1YMA; X-ray; 2.00 A; A=1-154.
DR   PDB; 1YMB; X-ray; 1.90 A; A=1-154.
DR   PDB; 1YMC; X-ray; 2.00 A; A=1-154.
DR   PDB; 2FRF; X-ray; 1.20 A; A=2-154.
DR   PDB; 2FRI; X-ray; 1.60 A; X=2-154.
DR   PDB; 2FRJ; X-ray; 1.30 A; X=2-154.
DR   PDB; 2FRK; X-ray; 1.30 A; X=2-154.
DR   PDB; 2IN4; X-ray; 2.15 A; A=1-154.
DR   PDB; 2NSR; X-ray; 1.90 A; A=2-154.
DR   PDB; 2NSS; X-ray; 2.00 A; A=2-154.
DR   PDB; 2O58; X-ray; 1.65 A; X=2-154.
DR   PDB; 2O5B; X-ray; 2.00 A; X=2-154.
DR   PDB; 2O5L; X-ray; 1.70 A; X=2-154.
DR   PDB; 2O5M; X-ray; 1.65 A; X=2-154.
DR   PDB; 2O5O; X-ray; 1.60 A; X=2-154.
DR   PDB; 2O5Q; X-ray; 1.90 A; X=2-154.
DR   PDB; 2O5S; X-ray; 1.60 A; X=2-154.
DR   PDB; 2O5T; X-ray; 1.60 A; X=2-154.
DR   PDB; 2V1E; X-ray; 1.30 A; A=2-154.
DR   PDB; 2V1F; X-ray; 1.20 A; A=2-154.
DR   PDB; 2V1G; X-ray; 1.35 A; A=2-154.
DR   PDB; 2V1H; X-ray; 1.30 A; A=2-154.
DR   PDB; 2V1I; X-ray; 1.20 A; A=2-154.
DR   PDB; 2V1J; X-ray; 1.40 A; A=2-154.
DR   PDB; 2V1K; X-ray; 1.25 A; A=2-154.
DR   PDB; 2VLY; X-ray; 1.60 A; A=2-154.
DR   PDB; 2VLZ; X-ray; 1.50 A; A=2-154.
DR   PDB; 2VM0; X-ray; 1.60 A; A=2-154.
DR   PDBsum; 1AZI; -.
DR   PDBsum; 1BJE; -.
DR   PDBsum; 1DWR; -.
DR   PDBsum; 1DWS; -.
DR   PDBsum; 1DWT; -.
DR   PDBsum; 1GJN; -.
DR   PDBsum; 1HRM; -.
DR   PDBsum; 1HSY; -.
DR   PDBsum; 1NPF; -.
DR   PDBsum; 1NPG; -.
DR   PDBsum; 1NZ2; -.
DR   PDBsum; 1NZ3; -.
DR   PDBsum; 1NZ4; -.
DR   PDBsum; 1NZ5; -.
DR   PDBsum; 1RSE; -.
DR   PDBsum; 1WLA; -.
DR   PDBsum; 1XCH; -.
DR   PDBsum; 1YMA; -.
DR   PDBsum; 1YMB; -.
DR   PDBsum; 1YMC; -.
DR   PDBsum; 2FRF; -.
DR   PDBsum; 2FRI; -.
DR   PDBsum; 2FRJ; -.
DR   PDBsum; 2FRK; -.
DR   PDBsum; 2IN4; -.
DR   PDBsum; 2NSR; -.
DR   PDBsum; 2NSS; -.
DR   PDBsum; 2O58; -.
DR   PDBsum; 2O5B; -.
DR   PDBsum; 2O5L; -.
DR   PDBsum; 2O5M; -.
DR   PDBsum; 2O5O; -.
DR   PDBsum; 2O5Q; -.
DR   PDBsum; 2O5S; -.
DR   PDBsum; 2O5T; -.
DR   PDBsum; 2V1E; -.
DR   PDBsum; 2V1F; -.
DR   PDBsum; 2V1G; -.
DR   PDBsum; 2V1H; -.
DR   PDBsum; 2V1I; -.
DR   PDBsum; 2V1J; -.
DR   PDBsum; 2V1K; -.
DR   PDBsum; 2VLY; -.
DR   PDBsum; 2VLZ; -.
DR   PDBsum; 2VM0; -.
DR   GeneID; 100054434; -.
DR   HOVERGEN; P68082; -.
DR   LinkHub; P68082; -.
DR   InterPro; IPR012292; Globin.
DR   InterPro; IPR000971; Globin_subset.
DR   InterPro; IPR002335; Myoglobin.
DR   Gene3D; G3DSA:1.10.490.10; Globin_related; 1.
DR   PANTHER; PTHR11442:SF5; Myoglobin; 1.
DR   Pfam; PF00042; Globin; 1.
DR   PRINTS; PR00613; MYOGLOBIN.
DR   PROSITE; PS01033; GLOBIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Heme; Iron; Metal-binding;
KW   Muscle protein; Oxygen transport; Transport.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    154       Myoglobin.
FT                                /FTId=PRO_0000053302.
FT   METAL        65     65       Iron (heme distal ligand).
FT   METAL        94     94       Iron (heme proximal ligand).
FT   CONFLICT    123    123       D -> N (in Ref. 1; AA sequence).
FT   HELIX         5     20
FT   HELIX        22     36
FT   HELIX        38     41
FT   TURN         45     49
FT   HELIX        53     57
FT   HELIX        60     77
FT   TURN         78     81
FT   HELIX        84     96
FT   HELIX       102    119
FT   HELIX       126    150
SQ   SEQUENCE   154 AA;  17083 MW;  20EABC4A66ACE975 CRC64;
     MGLSDGEWQQ VLNVWGKVEA DIAGHGQEVL IRLFTGHPET LEKFDKFKHL KTEAEMKASE
     DLKKHGTVVL TALGGILKKK GHHEAELKPL AQSHATKHKI PIKYLEFISD AIIHVLHSKH
     PGDFGADAQG AMTKALELFR NDIAAKYKEL GFQG
//
ID   MYG_AOTTR               Reviewed;         154 AA.
AC   P02151;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-JUN-2008, entry version 50.
DE   Myoglobin.
GN   Name=MB;
OS   Aotus trivirgatus (Night monkey) (Douroucouli).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Platyrrhini; Aotidae; Aotus.
OX   NCBI_TaxID=9505;
RN   [1]
RP   PROTEIN SEQUENCE OF 2-154.
RC   TISSUE=Skeletal muscle;
RX   MEDLINE=84108869; PubMed=6692912; DOI=10.1016/0014-5793(84)80012-5;
RA   Heinbokel N., Lehmann H.;
RT   "The myoglobin of primates: the Night monkey, Aotes trivirgatus
RT   (Cebidae, Platyrrhini, Anthropoidea).";
RL   FEBS Lett. 165:46-50(1984).
CC   -!- FUNCTION: Serves as a reserve supply of oxygen and facilitates the
CC       movement of oxygen within muscles.
CC   -!- SIMILARITY: Belongs to the globin family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   PIR; A02471; MYMQN.
DR   HSSP; P02189; 1MWC.
DR   SMR; P02151; 2-154.
DR   HOVERGEN; P02151; -.
DR   InterPro; IPR012292; Globin.
DR   InterPro; IPR000971; Globin_subset.
DR   InterPro; IPR002335; Myoglobin.
DR   Gene3D; G3DSA:1.10.490.10; Globin_related; 1.
DR   PANTHER; PTHR11442:SF5; Myoglobin; 1.
DR   Pfam; PF00042; Globin; 1.
DR   PRINTS; PR00613; MYOGLOBIN.
DR   PROSITE; PS01033; GLOBIN; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Heme; Iron; Metal-binding; Muscle protein;
KW   Oxygen transport; Transport.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    154       Myoglobin.
FT                                /FTId=PRO_0000053277.
FT   METAL        65     65       Iron (heme distal ligand).
FT   METAL        94     94       Iron (heme proximal ligand).
SQ   SEQUENCE   154 AA;  17161 MW;  41CD050945F00247 CRC64;
     MGLSDGEWQL VLNVWGKVEA DVPSHGQEVL ISLFKGHPET LEKFDKFKHL KSEDEMKASE
     ELKKHGVTVL TALGGILKKK GHHEAELKPL AQSHATKHKI PVKYLEFISD AIVHVLQKKH
     PGDFGADAQG AMKKALELFR NDMAAKYKEL GFQG
//
ID   MYG_HUMAN               Reviewed;         154 AA.
AC   P02144; Q52H51; Q5THY7;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-JUN-2008, entry version 88.
DE   Myoglobin.
GN   Name=MB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=84182508; PubMed=6571704;
RA   Weller P., Jeffreys A.J., Wilson V., Blanchetot A.;
RT   "Organization of the human myoglobin gene.";
RL   EMBO J. 3:439-446(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=85232026; PubMed=2989088; DOI=10.1016/0378-1119(85)90231-8;
RA   Akaboshi E.;
RT   "Cloning of the human myoglobin gene.";
RL   Gene 33:241-249(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:RESEARCH84.1-RESEARCH84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Livingston R.J., Rieder M.J., Shaffer T., Bertucci C., Baier C.N.,
RA   Rajkumar N., Willa H.T., Daniels M., Downing T.K., Stanaway I.B.,
RA   Nguyen C.P., Gildersleeve H., Cassidy C.M., Johnson E.J.,
RA   Swanson J.E., McFarland I., Yool B., Park C., Nickerson D.A.;
RT   "NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department
RT   of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu).";
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=20057165; PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-154.
RX   MEDLINE=71291923; PubMed=5285572;
RA   Romero-Herrera A.E., Lehmann H.;
RT   "Primary structure of human myoglobin.";
RL   Nature New Biol. 232:149-152(1971).
RN   [9]
RP   SEQUENCE REVISION TO 20-23 AND 84.
RX   PubMed=11452891;
RA   Romero-Herrera A.E., Lehmann H.;
RT   "The myoglobin of primates. I. Hylobates agilis (gibbon).";
RL   Biochim. Biophys. Acta 251:482-488(1971).
RN   [10]
RP   SEQUENCE REVISION TO 100-102.
RX   MEDLINE=73002055; PubMed=4627044;
RA   Romero-Herrera A.E., Lehmann H.;
RT   "The myoglobin of primates. II. Pan troglodytes (chimpanzee).";
RL   Biochim. Biophys. Acta 278:62-67(1972).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-21.
RC   TISSUE=Heart;
RX   MEDLINE=95203287; PubMed=7895732;
RA   Corbett J.M., Wheeler C.H., Baker C.S., Yacoub M.H., Dunn M.J.;
RT   "The human myocardial two-dimensional gel protein database: update
RT   1994.";
RL   Electrophoresis 15:1459-1465(1994).
RN   [12]
RP   VARIANT LYS-55.
RX   MEDLINE=69275845; PubMed=5805522;
RA   Boulton F.E., Huntsman R.G., Lorkin P.A., Lehmann H.;
RT   "Abnormal human myoglobin: 53 (D4) glutamic acid-->lysine.";
RL   Nature 223:832-833(1969).
RN   [13]
RP   VARIANT TRP-140.
RX   MEDLINE=71177026; PubMed=5555219;
RA   Boulton F.E., Huntsman R.G., Romero Herrera A., Lorkin P.A.,
RA   Lehmann H.;
RT   "The third variant of human myoglobin showing an unusual amino acid
RT   substitution: 138(H16)arginine-->tryptophan.";
RL   Biochim. Biophys. Acta 229:716-719(1971).
RN   [14]
RP   VARIANT ASN-134.
RX   MEDLINE=71177044; PubMed=5555226;
RA   Boulton F.E., Huntsman R.G., Romero Herrera A.E., Lorkin P.A.,
RA   Lehmann H.;
RT   "A human myoglobin variant 133 (H-10)lysine-->asparagine.";
RL   Biochim. Biophys. Acta 229:871-876(1971).
RN   [15]
RP   VARIANT GLN-140.
RX   MEDLINE=71085676; PubMed=5540041;
RA   Boulton F.E., Huntsman R.G., Yawson G.I., Romero-Herrera A.E.,
RA   Lorkin P.A.;
RT   "The second variant of human myoglobin; 138(H16) arginine leads to
RT   glutamine.";
RL   Br. J. Haematol. 20:69-74(1971).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF MUTANT WITH ARG-46 AND
RP   ALA-111.
RX   MEDLINE=90258028; PubMed=2342104; DOI=10.1016/S0022-2836(05)80181-0;
RA   Hubbard S.R., Hendrickson W.A., Lambright D.G., Boxer S.G.;
RT   "X-ray crystal structure of a recombinant human myoglobin mutant at
RT   2.8-A resolution.";
RL   J. Mol. Biol. 213:215-218(1990).
CC   -!- FUNCTION: Serves as a reserve supply of oxygen and facilitates the
CC       movement of oxygen within muscles.
CC   -!- SIMILARITY: Belongs to the globin family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00371; CAA25109.1; -; Genomic_DNA.
DR   EMBL; X00372; CAA25109.1; JOINED; Genomic_DNA.
DR   EMBL; X00373; CAA25109.1; JOINED; Genomic_DNA.
DR   EMBL; M14603; AAA59595.1; -; Genomic_DNA.
DR   EMBL; M10090; AAA59595.1; JOINED; Genomic_DNA.
DR   EMBL; M14602; AAA59595.1; JOINED; Genomic_DNA.
DR   EMBL; CR456516; CAG30402.1; -; mRNA.
DR   EMBL; CR541949; CAG46747.1; -; mRNA.
DR   EMBL; DQ003030; AAX84516.1; -; Genomic_DNA.
DR   EMBL; AL022334; CAI21837.1; -; Genomic_DNA.
DR   EMBL; AL049747; CAI21837.1; JOINED; Genomic_DNA.
DR   EMBL; AL049747; CAI23587.1; -; Genomic_DNA.
DR   EMBL; AL022334; CAI23587.1; JOINED; Genomic_DNA.
DR   EMBL; BC014547; AAH14547.1; -; mRNA.
DR   PIR; I53991; MYHU.
DR   RefSeq; NP_005359.1; -.
DR   RefSeq; NP_976311.1; -.
DR   RefSeq; NP_976312.1; -.
DR   UniGene; Hs.517586; -.
DR   PDB; 2MM1; X-ray; 2.80 A; A=1-154.
DR   PDBsum; 2MM1; -.
DR   PhosphoSite; P02144; -.
DR   HSC-2DPAGE; P02144; -.
DR   PeptideAtlas; P02144; -.
DR   Ensembl; ENSG00000198125; Homo sapiens.
DR   GeneID; 4151; -.
DR   KEGG; hsa:4151; -.
DR   H-InvDB; HIX0016418; -.
DR   HGNC; HGNC:6915; MB.
DR   HPA; CAB000060; -.
DR   HPA; HPA003123; -.
DR   MIM; 160000; gene.
DR   PharmGKB; PA134917460; -.
DR   HOGENOM; P02144; -.
DR   HOVERGEN; P02144; -.
DR   LinkHub; P02144; -.
DR   ArrayExpress; P02144; -.
DR   CleanEx; HS_MB; -.
DR   GermOnline; ENSG00000198125; Homo sapiens.
DR   InterPro; IPR012292; Globin.
DR   InterPro; IPR000971; Globin_subset.
DR   InterPro; IPR002335; Myoglobin.
DR   Gene3D; G3DSA:1.10.490.10; Globin_related; 1.
DR   PANTHER; PTHR11442:SF5; Myoglobin; 1.
DR   Pfam; PF00042; Globin; 1.
DR   PRINTS; PR00613; MYOGLOBIN.
DR   PROSITE; PS01033; GLOBIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Heme; Iron; Metal-binding;
KW   Muscle protein; Oxygen transport; Polymorphism; Transport.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    154       Myoglobin.
FT                                /FTId=PRO_0000053303.
FT   METAL        65     65       Iron (heme distal ligand).
FT   METAL        94     94       Iron (heme proximal ligand).
FT   VARIANT      55     55       E -> K.
FT                                /FTId=VAR_003180.
FT   VARIANT     134    134       K -> N.
FT                                /FTId=VAR_003181.
FT   VARIANT     140    140       R -> Q.
FT                                /FTId=VAR_003182.
FT   VARIANT     140    140       R -> W.
FT                                /FTId=VAR_003183.
FT   CONFLICT    106    106       E -> Q (in Ref. 5; AAX84516).
FT   CONFLICT    129    129       Q -> E (in Ref. 2; AAA59595).
FT   HELIX         5     18
FT   HELIX        22     36
FT   HELIX        38     42
FT   TURN         46     49
FT   HELIX        53     58
FT   HELIX        60     77
FT   TURN         78     81
FT   HELIX        84     96
FT   HELIX       103    119
FT   HELIX       121    123
FT   HELIX       126    149
SQ   SEQUENCE   154 AA;  17184 MW;  F6A41F19A525F09C CRC64;
     MGLSDGEWQL VLNVWGKVEA DIPGHGQEVL IRLFKGHPET LEKFDKFKHL KSEDEMKASE
     DLKKHGATVL TALGGILKKK GHHEAEIKPL AQSHATKHKI PVKYLEFISE CIIQVLQSKH
     PGDFGADAQG AMNKALELFR KDMASNYKEL GFQG
//
ID   TRYP_PIG                Reviewed;         231 AA.
AC   P00761;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   10-JUN-2008, entry version 79.
DE   Trypsin precursor (EC 3.4.21.4).
OS   Sus scrofa (Pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Suina; Suidae;
OC   Sus.
OX   NCBI_TaxID=9823;
RN   [1]
RP   PROTEIN SEQUENCE OF 1-10.
RX   MEDLINE=62212193; PubMed=14020231; DOI=10.1016/0006-3002(63)91231-9;
RA   Charles M., Rovery M., Guidoni A.A., Desnuelle P.;
RT   "On trypsinogen and trypsin of pig.";
RL   Biochim. Biophys. Acta 69:115-129(1963).
RN   [2]
RP   PROTEIN SEQUENCE OF 9-231.
RX   MEDLINE=73258692; PubMed=4738933; DOI=10.1021/bi00741a002;
RA   Hermodson M.A., Ericsson L.H., Neurath H., Walsh K.A.;
RT   "Determination of the amino acid sequence of porcine trypsin by
RT   sequenator analysis.";
RL   Biochemistry 12:3146-3153(1973).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS).
RX   MEDLINE=93187998; PubMed=8445634; DOI=10.1006/jmbi.1993.1102;
RA   Huang Q., Liu S., Tang Y.;
RT   "Refined 1.6-A resolution crystal structure of the complex formed
RT   between porcine beta-trypsin and MCTI-A, a trypsin inhibitor of the
RT   squash family. Detailed comparison with bovine beta-trypsin and its
RT   complex.";
RL   J. Mol. Biol. 229:1022-1030(1993).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS).
RX   MEDLINE=92201369; PubMed=1551419; DOI=10.1016/0014-5793(92)80346-I;
RA   Huang Q., Liu S., Tang Y., Zeng F., Qian R.;
RT   "Amino acid sequencing of a trypsin inhibitor by refined 1.6 A X-ray
RT   crystal structure of its complex with porcine beta-trypsin.";
RL   FEBS Lett. 297:143-146(1992).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   MEDLINE=95035057; PubMed=7947985; DOI=10.1016/0167-4838(94)90139-2;
RA   Huang Q., Wang Z., Li Y., Liu S., Tang Y.;
RT   "Refined 1.8-A resolution crystal structure of the porcine epsilon-
RT   trypsin.";
RL   Biochim. Biophys. Acta 1209:77-82(1994).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF COMPLEX WITH LDTI.
RX   MEDLINE=97390427; PubMed=9242660; DOI=10.1074/jbc.272.32.19931;
RA   Stubbs M.T., Morenweiser R., Stuerzebecher J., Bauer M., Bode W.,
RA   Huber R., Piechottka G.P., Matschiner G., Sommerhoff C.P., Fritz H.,
RA   Auerswald E.A.;
RT   "The three-dimensional structure of recombinant leech-derived tryptase
RT   inhibitor in complex with trypsin. Implications for the structure of
RT   human mast cell tryptase and its inhibition.";
RL   J. Biol. Chem. 272:19931-19937(1997).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.03 ANGSTROMS) OF COMPLEX WITH LDTI.
RX   MEDLINE=98046095; PubMed=9384562; DOI=10.1016/S0969-2126(97)00296-7;
RA   di Marco S., Priestle J.P.;
RT   "Structure of the complex of leech-derived tryptase inhibitor (LDTI)
RT   with trypsin and modeling of the LDTI-tryptase system.";
RL   Structure 5:1465-1474(1997).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF COMPLEX WITH BDELLASTASIN.
RX   MEDLINE=20235652; PubMed=10771427; DOI=10.1107/S0907444900003048;
RA   Rester U., Moser M., Huber R., Bode W.;
RT   "L-isoaspartate 115 of porcine beta-trypsin promotes crystallization
RT   of its complex with bdellastasin.";
RL   Acta Crystallogr. D 56:581-588(2000).
CC   -!- CATALYTIC ACTIVITY: Preferential cleavage: Arg-|-Xaa, Lys-|-Xaa.
CC   -!- COFACTOR: Binds 1 calcium ion per subunit.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC   -!- SIMILARITY: Contains 1 peptidase S1 domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   PIR; A90641; TRPGTR.
DR   PDB; 1AKS; X-ray; 1.80 A; A=9-133, B=134-231.
DR   PDB; 1AN1; X-ray; 2.03 A; E=9-231.
DR   PDB; 1AVW; X-ray; 1.75 A; A=9-231.
DR   PDB; 1AVX; X-ray; 1.90 A; A=9-231.
DR   PDB; 1C9P; X-ray; 2.80 A; A=9-231.
DR   PDB; 1D3O; Model; -; A=9-231.
DR   PDB; 1DF2; Model; -; A=9-231.
DR   PDB; 1EJA; X-ray; 2.70 A; A=9-231.
DR   PDB; 1EPT; X-ray; 1.80 A; A=9-51, B=52-133, C=134-231.
DR   PDB; 1EWU; Model; -; A=9-231.
DR   PDB; 1FMG; X-ray; 1.90 A; A=9-231.
DR   PDB; 1FN6; X-ray; 1.80 A; A=9-231.
DR   PDB; 1FNI; X-ray; 1.60 A; A=9-231.
DR   PDB; 1H9H; X-ray; 1.50 A; E=9-231.
DR   PDB; 1H9I; X-ray; 1.90 A; E=9-231.
DR   PDB; 1LDT; X-ray; 1.90 A; T=9-231.
DR   PDB; 1LT2; Model; -; A=9-231.
DR   PDB; 1MCT; X-ray; 1.60 A; A=9-231.
DR   PDB; 1QQU; X-ray; 1.63 A; A=9-231.
DR   PDB; 1S5S; X-ray; 1.40 A; A=9-231.
DR   PDB; 1S6F; X-ray; 1.80 A; A=9-231.
DR   PDB; 1S6H; X-ray; 1.45 A; A=9-231.
DR   PDB; 1S81; X-ray; 1.70 A; A=9-231.
DR   PDB; 1S82; X-ray; 1.85 A; A=9-231.
DR   PDB; 1S83; X-ray; 1.25 A; A=9-231.
DR   PDB; 1S84; X-ray; 1.85 A; A=9-231.
DR   PDB; 1S85; X-ray; 2.20 A; A=9-231.
DR   PDB; 1TFX; X-ray; 2.60 A; A/B=9-231.
DR   PDB; 1TX6; X-ray; 2.20 A; A/B/C/D=9-231.
DR   PDB; 1UHB; X-ray; 2.15 A; A=9-133, B=134-231, P=177-185.
DR   PDB; 1V6D; X-ray; 1.90 A; A=9-231.
DR   PDB; 1YF4; X-ray; 1.98 A; A=9-231.
DR   PDB; 1Z7K; X-ray; 1.90 A; A=9-231.
DR   PDB; 2A31; X-ray; 1.25 A; A=9-231.
DR   PDB; 2A32; X-ray; 1.50 A; A=9-231.
DR   PDBsum; 1AKS; -.
DR   PDBsum; 1AN1; -.
DR   PDBsum; 1AVW; -.
DR   PDBsum; 1AVX; -.
DR   PDBsum; 1C9P; -.
DR   PDBsum; 1D3O; -.
DR   PDBsum; 1DF2; -.
DR   PDBsum; 1EJA; -.
DR   PDBsum; 1EPT; -.
DR   PDBsum; 1EWU; -.
DR   PDBsum; 1FMG; -.
DR   PDBsum; 1FN6; -.
DR   PDBsum; 1FNI; -.
DR   PDBsum; 1H9H; -.
DR   PDBsum; 1H9I; -.
DR   PDBsum; 1LDT; -.
DR   PDBsum; 1LT2; -.
DR   PDBsum; 1MCT; -.
DR   PDBsum; 1QQU; -.
DR   PDBsum; 1S5S; -.
DR   PDBsum; 1S6F; -.
DR   PDBsum; 1S6H; -.
DR   PDBsum; 1S81; -.
DR   PDBsum; 1S82; -.
DR   PDBsum; 1S83; -.
DR   PDBsum; 1S84; -.
DR   PDBsum; 1S85; -.
DR   PDBsum; 1TFX; -.
DR   PDBsum; 1TX6; -.
DR   PDBsum; 1UHB; -.
DR   PDBsum; 1V6D; -.
DR   PDBsum; 1YF4; -.
DR   PDBsum; 1Z7K; -.
DR   PDBsum; 2A31; -.
DR   PDBsum; 2A32; -.
DR   DIP; DIP:6083N; -.
DR   MEROPS; S01.151; -.
DR   HOVERGEN; P00761; -.
DR   LinkHub; P00761; -.
DR   GO; GO:0004295; F:trypsin activity; IEA:EC.
DR   InterPro; IPR001254; Peptidase_S1_S6.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Digestion; Direct protein sequencing;
KW   Hydrolase; Metal-binding; Protease; Secreted; Serine protease;
KW   Zymogen.
FT   PROPEP        1      8       Activation peptide.
FT                                /FTId=PRO_0000028205.
FT   CHAIN         9    231       Trypsin.
FT                                /FTId=PRO_0000028206.
FT   DOMAIN        9    229       Peptidase S1.
FT   ACT_SITE     48     48       Charge relay system.
FT   ACT_SITE     92     92       Charge relay system.
FT   ACT_SITE    185    185       Charge relay system.
FT   METAL        60     60       Calcium.
FT   METAL        62     62       Calcium (via carbonyl oxygen).
FT   METAL        65     65       Calcium (via carbonyl oxygen).
FT   METAL        70     70       Calcium.
FT   SITE        179    179       Required for specificity (By similarity).
FT   DISULFID     15    145
FT   DISULFID     33     49
FT   DISULFID    117    218
FT   DISULFID    124    191
FT   DISULFID    156    170
FT   DISULFID    181    205
FT   VARIANT      20     20       I -> V.
FT   STRAND       23     39
FT   STRAND       42     45
FT   HELIX        47     49
FT   STRAND       55     59
FT   STRAND       71     80
FT   TURN         86     88
FT   STRAND       94    100
FT   STRAND      105    108
FT   STRAND      123    129
FT   STRAND      134    136
FT   STRAND      144    150
FT   HELIX       153    159
FT   TURN        161    163
FT   STRAND      168    172
FT   STRAND      188    191
FT   STRAND      194    206
FT   STRAND      212    216
FT   HELIX       217    219
FT   HELIX       221    229
SQ   SEQUENCE   231 AA;  24409 MW;  A0A125CF7FC138C2 CRC64;
     FPTDDDDKIV GGYTCAANSI PYQVSLNSGS HFCGGSLINS QWVVSAAHCY KSRIQVRLGE
     HNIDVLEGNE QFINAAKIIT HPNFNGNTLD NDIMLIKLSS PATLNSRVAT VSLPRSCAAA
     GTECLISGWG NTKSSGSSYP SLLQCLKAPV LSDSSCKSSY PGQITGNMIC VGFLEGGKDS
     CQGDSGGPVV CNGQLQGIVS WGYGCAQKNK PGVYTKVCNY VNWIQQTIAA N
//
ID   ALBU_BOVIN              Reviewed;         607 AA.
AC   P02769; A5PJX3; O02787; P04277; Q3SZR2;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 4.
DT   01-JUL-2008, entry version 87.
DE   Serum albumin precursor (BSA) (Allergen Bos d 6).
GN   Name=ALB;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Holowachuk E.W., Stoltenborg J.K., Reed R.G., Peters T. Jr.;
RT   "Bovine serum albumin: cDNA sequence and expression.";
RL   Submitted (AUG-1991) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-214.
RC   TISSUE=Liver;
RA   Barry T., Power S., Gannon F.;
RT   "The bovine serum albumin mRNA.";
RL   Submitted (JUL-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   MEDLINE=21195144; PubMed=11298124;
RX   DOI=10.1046/j.1365-2249.2001.01451.x;
RA   Hilger C., Grigioni F., De Beaufort C., Michel G., Freilinger J.,
RA   Hentges F.;
RT   "Differential binding of IgG and IgA antibodies to antigenic
RT   determinants of bovine serum albumin.";
RL   Clin. Exp. Immunol. 123:387-394(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-214.
RA   Wu H.T., Huang M.C.;
RT   "The complete cDNA sequence of bovine serum albumin.";
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-214.
RC   STRAIN=Hereford; TISSUE=Fetal liver, and Testis;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PROTEIN SEQUENCE OF 1-32.
RX   MEDLINE=80024278; PubMed=488109;
RA   McGillivray R.T.A., Chung D.W., Davie E.W.;
RT   "Biosynthesis of bovine plasma proteins in a cell-free system. Amino-
RT   terminal sequence of preproalbumin.";
RL   Eur. J. Biochem. 98:477-485(1979).
RN   [7]
RP   PROTEIN SEQUENCE OF 19-28.
RX   MEDLINE=77134075; PubMed=843354; DOI=10.1016/0006-291X(77)91648-5;
RA   Patterson J.E., Geller D.M.;
RT   "Bovine microsomal albumin: amino terminal sequence of bovine
RT   proalbumin.";
RL   Biochem. Biophys. Res. Commun. 74:1220-1226(1977).
RN   [8]
RP   PROTEIN SEQUENCE, AND SEQUENCE REVISION TO 118-119 AND 180.
RX   MEDLINE=91083649; PubMed=2260975; DOI=10.1016/S0006-291X(05)80083-X;
RA   Hirayama K., Akashi S., Furuya M., Fukuhara K.;
RT   "Rapid confirmation and revision of the primary structure of bovine
RT   serum albumin by ESIMS and Frit-FAB LC/MS.";
RL   Biochem. Biophys. Res. Commun. 173:639-646(1990).
RN   [9]
RP   PROTEIN SEQUENCE OF 25-424 AND 429-607, AND VARIANT THR-214.
RA   Brown J.R.;
RT   "Structure of bovine serum albumin.";
RL   Fed. Proc. 34:591-591(1975).
RN   [10]
RP   SEQUENCE REVISION TO 190-195.
RA   Brown J.R.;
RL   Submitted (APR-1975) to the PIR data bank.
RN   [11]
RP   PROTEIN SEQUENCE OF 25-64.
RX   PubMed=2379503;
RA   Strawich E., Glimcher M.J.;
RT   "Tooth 'enamelins' identified mainly as serum proteins. Major
RT   'enamelin' is albumin.";
RL   Eur. J. Biochem. 191:47-56(1990).
RN   [12]
RP   PROTEIN SEQUENCE OF 25-41.
RX   MEDLINE=88267456; PubMed=3389500; DOI=10.1016/0003-2697(88)90082-6;
RA   Hsieh J.C., Lin F.P., Tam M.F.;
RT   "Electroblotting onto glass-fiber filter from an analytical
RT   isoelectrofocusing gel: a preparative method for isolating proteins
RT   for N-terminal microsequencing.";
RL   Anal. Biochem. 170:1-8(1988).
RN   [13]
RP   PROTEIN SEQUENCE OF 163-172.
RX   MEDLINE=89341406; PubMed=2474609;
RA   Carraway R.E., Cochrane D.E., Boucher W., Mitra S.P.;
RT   "Structures of histamine-releasing peptides formed by the action of
RT   acid proteases on mammalian albumin(s).";
RL   J. Immunol. 143:1680-1684(1989).
RN   [14]
RP   PROTEIN SEQUENCE OF 165-173.
RC   TISSUE=Plasma;
RX   MEDLINE=87194805; PubMed=2437111;
RA   Carraway R.E., Mitra S.P., Cochrane D.E.;
RT   "Structure of a biologically active neurotensin-related peptide
RT   obtained from pepsin-treated albumin(s).";
RL   J. Biol. Chem. 262:5968-5973(1987).
RN   [15]
RP   PROTEIN SEQUENCE OF 402-433.
RX   MEDLINE=82023364; PubMed=7283978;
RA   Reed R.G., Putnam F.W., Peters T. Jr.;
RT   "Sequence of residues 400-403 of bovine serum albumin.";
RL   Biochem. J. 191:867-868(1980).
RN   [16]
RP   PROTEIN SEQUENCE OF 437-451.
RA   Vilbois F.;
RL   Submitted (AUG-1998) to UniProtKB.
RN   [17]
RP   DISULFIDE BONDS.
RA   Brown J.R.;
RT   "Structure of serum albumin: disulfide bridges.";
RL   Fed. Proc. 33:1389-1389(1974).
CC   -!- FUNCTION: Serum albumin, the main protein of plasma, has a good
CC       binding capacity for water, Ca(2+), Na(+), K(+), fatty acids,
CC       hormones, bilirubin and drugs. Its main function is the regulation
CC       of the colloidal osmotic pressure of blood.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Plasma.
CC   -!- ALLERGEN: Causes an allergic reaction in human.
CC   -!- SIMILARITY: Belongs to the ALB/AFP/VDB family.
CC   -!- SIMILARITY: Contains 3 albumin domains.
CC   -!- CAUTION: A peptide arising from positions 165 to 173 was
CC       originally (PubMed:2437111) termed neurotensin-related peptide
CC       (NRP) and was thought to regulates fat digestion, lipid
CC       absorption, and blood flow.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M73993; AAA51411.1; -; mRNA.
DR   EMBL; X58989; CAA41735.1; -; mRNA.
DR   EMBL; Y17769; CAA76847.1; -; mRNA.
DR   EMBL; AF542068; AAN17824.1; -; mRNA.
DR   EMBL; BC102742; AAI02743.1; -; mRNA.
DR   EMBL; BC142272; AAI42273.1; -; mRNA.
DR   PIR; A38885; ABBOS.
DR   RefSeq; NP_851335.1; -.
DR   UniGene; Bt.48997; -.
DR   HSSP; P02768; 1HK1.
DR   SMR; P02769; 27-607.
DR   Ensembl; ENSBTAG00000017121; Bos taurus.
DR   GeneID; 280717; -.
DR   KEGG; bta:280717; -.
DR   HOVERGEN; P02769; -.
DR   GO; GO:0043234; C:protein complex; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0008144; F:drug binding; ISS:UniProtKB.
DR   GO; GO:0005504; F:fatty acid binding; ISS:UniProtKB.
DR   GO; GO:0005515; F:protein binding; ISS:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; ISS:UniProtKB.
DR   GO; GO:0015643; F:toxin binding; ISS:UniProtKB.
DR   GO; GO:0009267; P:cellular response to starvation; ISS:UniProtKB.
DR   GO; GO:0019836; P:hemolysis by symbiont of host red blood cells; ISS:UniProtKB.
DR   GO; GO:0051659; P:maintenance of mitochondrion location; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptosis; ISS:UniProtKB.
DR   InterPro; IPR001703; Alphafetoprot.
DR   InterPro; IPR000264; Serum_albumin.
DR   InterPro; IPR014760; Serum_albumin_N.
DR   Pfam; PF00273; Serum_albumin; 3.
DR   PRINTS; PR00803; AFETOPROTEIN.
DR   PRINTS; PR00802; SERUMALBUMIN.
DR   ProDom; PD002486; Serum_albumin; 1.
DR   SMART; SM00103; ALBUMIN; 3.
DR   PROSITE; PS00212; ALBUMIN; 3.
PE   1: Evidence at protein level;
KW   Allergen; Cleavage on pair of basic residues; Copper;
KW   Direct protein sequencing; Lipid-binding; Metal-binding;
KW   Phosphoprotein; Polymorphism; Repeat; Secreted; Signal.
FT   SIGNAL        1     18
FT   PROPEP       19     24
FT                                /FTId=PRO_0000001057.
FT   CHAIN        25    607       Serum albumin.
FT                                /FTId=PRO_0000001058.
FT   DOMAIN       25    204       Albumin 1.
FT   DOMAIN      211    396       Albumin 2.
FT   DOMAIN      403    594       Albumin 3.
FT   METAL        27     27       Copper (By similarity).
FT   MOD_RES      82     82       Phosphoserine (By similarity).
FT   DISULFID     77     86
FT   DISULFID     99    115
FT   DISULFID    114    125
FT   DISULFID    147    192
FT   DISULFID    191    200
FT   DISULFID    223    269
FT   DISULFID    268    276
FT   DISULFID    288    302
FT   DISULFID    301    312
FT   DISULFID    339    384
FT   DISULFID    383    392
FT   DISULFID    415    461
FT   DISULFID    460    471
FT   DISULFID    484    500
FT   DISULFID    499    510
FT   DISULFID    537    582
FT   DISULFID    581    590
FT   VARIANT     214    214       A -> T.
FT   CONFLICT     58     58       Missing (in Ref. 11; AA sequence).
FT   CONFLICT    116    116       E -> A (in Ref. 5; AAI02743).
FT   CONFLICT    173    173       Y -> L (in Ref. 14; AA sequence).
FT   CONFLICT    302    302       C -> K (in Ref. 9; AA sequence).
FT   CONFLICT    304    305       KP -> PC (in Ref. 9; AA sequence).
FT   CONFLICT    324    324       N -> D (in Ref. 9; AA sequence).
FT   CONFLICT    394    395       ST -> TS (in Ref. 9; AA sequence).
FT   CONFLICT    429    429       A -> E (in Ref. 5; AAI02743).
FT   CONFLICT    437    437       K -> R (in Ref. 16; AA sequence).
FT   CONFLICT    472    472       T -> A (in Ref. 5; AAI02743).
FT   CONFLICT    493    494       SE -> ES (in Ref. 9; AA sequence).
FT   CONFLICT    579    579       D -> G (in Ref. 5; AAI02743).
SQ   SEQUENCE   607 AA;  69293 MW;  39167DFE768585D4 CRC64;
     MKWVTFISLL LLFSSAYSRG VFRRDTHKSE IAHRFKDLGE EHFKGLVLIA FSQYLQQCPF
     DEHVKLVNEL TEFAKTCVAD ESHAGCEKSL HTLFGDELCK VASLRETYGD MADCCEKQEP
     ERNECFLSHK DDSPDLPKLK PDPNTLCDEF KADEKKFWGK YLYEIARRHP YFYAPELLYY
     ANKYNGVFQE CCQAEDKGAC LLPKIETMRE KVLASSARQR LRCASIQKFG ERALKAWSVA
     RLSQKFPKAE FVEVTKLVTD LTKVHKECCH GDLLECADDR ADLAKYICDN QDTISSKLKE
     CCDKPLLEKS HCIAEVEKDA IPENLPPLTA DFAEDKDVCK NYQEAKDAFL GSFLYEYSRR
     HPEYAVSVLL RLAKEYEATL EECCAKDDPH ACYSTVFDKL KHLVDEPQNL IKQNCDQFEK
     LGEYGFQNAL IVRYTRKVPQ VSTPTLVEVS RSLGKVGTRC CTKPESERMP CTEDYLSLIL
     NRLCVLHEKT PVSEKVTKCC TESLVNRRPC FSALTPDETY VPKAFDEKLF TFHADICTLP
     DTEKQIKKQT ALVELLKHKP KATEEQLKTV MENFVAFVDK CCAADDKEAC FAVEGPKLVV
     STQTALA
//
ID   PYGM_RABIT              Reviewed;         843 AA.
AC   P00489;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-JUN-2008, entry version 92.
DE   Glycogen phosphorylase, muscle form (EC 2.4.1.1) (Myophosphorylase).
GN   Name=PYGM;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae;
OC   Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=86275269; PubMed=3015680; DOI=10.1016/0014-5793(86)80829-8;
RA   Nakano K., Hwang P.K., Fletterick R.J.;
RT   "Complete cDNA sequence for rabbit muscle glycogen phosphorylase.";
RL   FEBS Lett. 204:283-287(1986).
RN   [2]
RP   PROTEIN SEQUENCE OF 2-351.
RX   MEDLINE=79082846; PubMed=728424; DOI=10.1021/bi00619a012;
RA   Koide A., Titani K., Ericsson L.H., Kumar S., Neurath H., Walsh K.A.;
RT   "Sequence of the amino-terminal 349 residues of rabbit muscle glycogen
RT   phosphorylase including the sites of covalent and allosteric
RT   control.";
RL   Biochemistry 17:5657-5672(1978).
RN   [3]
RP   PROTEIN SEQUENCE OF 352-429 AND 443-605.
RX   MEDLINE=79082847; PubMed=728425; DOI=10.1021/bi00619a013;
RA   Hermann J., Titani K., Ericsson L.H., Wade R.D., Neurath H.,
RA   Walsh K.A.;
RT   "Amino acid sequence of two cyanogen bromide fragments of glycogen
RT   phosphorylase.";
RL   Biochemistry 17:5672-5679(1978).
RN   [4]
RP   PROTEIN SEQUENCE OF 352-843.
RX   MEDLINE=79082848; PubMed=728426; DOI=10.1021/bi00619a014;
RA   Titani K., Koide A., Ericsson L.H., Kumar S., Hermann J., Wade R.D.,
RA   Walsh K.A., Neurath H., Fischer E.H.;
RT   "Sequence of the carboxyl-terminal 492 residues of rabbit muscle
RT   glycogen phosphorylase including the pyridoxal 5'-phosphate binding
RT   site.";
RL   Biochemistry 17:5680-5693(1978).
RN   [5]
RP   PROTEIN SEQUENCE OF 71-81.
RX   MEDLINE=78218229; PubMed=670209;
RA   Lee Y.M., Benisek W.F.;
RT   "Inactivation of phosphorylase b by potassium ferrate. Identification
RT   of a tyrosine residue involved in the binding of adenosine 5'-
RT   monophosphate.";
RL   J. Biol. Chem. 253:5460-5463(1978).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 575-843.
RX   MEDLINE=86030264; PubMed=3840433;
RA   Hwang P.K., See Y.P., Vincentini A.M., Powers M.A., Fletterick R.J.,
RA   Crerar M.M.;
RT   "Comparative sequence analysis of rat, rabbit, and human muscle
RT   glycogen phosphorylase cDNAs.";
RL   Eur. J. Biochem. 152:267-274(1985).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF PHOSPHORYLASE A.
RX   MEDLINE=79082849; PubMed=728427;
RA   Sprang S.R., Fletterick R.J.;
RT   "Crystallographic analysis of phosphorylase alpha at 2.5-A resolution,
RT   a comment on the chemical sequence.";
RL   Biochemistry 17:5693-5694(1978).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF PHOSPHORYLASE A.
RX   MEDLINE=89332518; PubMed=2756432;
RA   Goldsmith E.J., Sprang S.R., Hamlin R., Xuong N.-H., Fletterick R.J.;
RT   "Domain separation in the activation of glycogen phosphorylase a.";
RL   Science 245:528-532(1989).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF PHOSPHORYLASE A WITH AMP.
RX   MEDLINE=87292128; PubMed=3616621;
RA   Sprang S.R., Goldsmith E.J., Fletterick R.J.;
RT   "Structure of the nucleotide activation switch in glycogen
RT   phosphorylase a.";
RL   Science 237:1012-1019(1987).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF PHOSPHORYLASE B.
RX   MEDLINE=79082850; PubMed=728428;
RA   Jenkins J.A., Johnson L.N., Wilson K.S.;
RT   "Assignment of the amino acid sequence to the crystal structure of
RT   glycogen phosphorylase b.";
RL   Biochemistry 17:5694-5695(1978).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF PHOSPHORYLASE B.
RX   MEDLINE=96107378; PubMed=7500360; DOI=10.1006/jmbi.1995.0665;
RA   Oikonomakos N.G., Zographos S.E., Johnson L.N., Papageorgiou A.C.,
RA   Acharya K.R.;
RT   "The binding of 2-deoxy-D-glucose 6-phosphate to glycogen
RT   phosphorylase b: kinetic and crystallographic studies.";
RL   J. Mol. Biol. 254:900-917(1995).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF PHOSPHORYLASE B.
RX   MEDLINE=97130834; PubMed=8976550;
RA   Oikonomakos N.G., Zographos S.E., Tsitsanou K.E., Johnson L.N.,
RA   Acharya K.R.;
RT   "Activator anion binding site in pyridoxal phosphorylase b: the
RT   binding of phosphite, phosphate, and fluorophosphate in the crystal.";
RL   Protein Sci. 5:2416-2428(1996).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.99 ANGSTROMS) OF PHOSPHORYLASE B.
RX   MEDLINE=98227853; PubMed=9568898;
RA   Gregoriou M., Noble M.E.M., Watson K.A., Garman E.F., Krulle T.M.,
RA   de la Fuente C., Fleet G.W., Oikonomakos N.G., Johnson L.N.;
RT   "The structure of a glycogen phosphorylase glucopyranose
RT   spirohydantoin complex at 1.8-A resolution and 100 K: the role of the
RT   water structure and its contribution to binding.";
RL   Protein Sci. 7:915-927(1998).
CC   -!- FUNCTION: Phosphorylase is an important allosteric enzyme in
CC       carbohydrate metabolism. Enzymes from different sources differ in
CC       their regulatory mechanisms and in their natural substrates.
CC       However, all known phosphorylases share catalytic and structural
CC       properties.
CC   -!- CATALYTIC ACTIVITY: (1,4-alpha-D-glucosyl)(n) + phosphate = (1,4-
CC       alpha-D-glucosyl)(n-1) + alpha-D-glucose 1-phosphate.
CC   -!- COFACTOR: Pyridoxal phosphate.
CC   -!- ENZYME REGULATION: Activity of phosphorylase is controlled both by
CC       allosteric means (through the noncovalent binding of metabolites)
CC       and by covalent modification. Thus AMP allosterically activates,
CC       whereas ATP, ADP, and glucose-6-phosphate allosterically inhibit,
CC       phosphorylase B.
CC   -!- SUBUNIT: Homodimer. Dimers associate into a tetramer to form the
CC       enzymatically active phosphorylase A.
CC   -!- PTM: Phosphorylation of Ser-15 converts phosphorylase B
CC       (unphosphorylated) to phosphorylase A.
CC   -!- SIMILARITY: Belongs to the glycogen phosphorylase family.
CC   -!- WEB RESOURCE: Name=ProZyme technical fact sheet;
CC       URL="http://www.prozyme.com/pdf/mw10.pdf";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D00040; BAA00027.1; -; mRNA.
DR   EMBL; X04265; CAA27816.1; -; mRNA.
DR   EMBL; X03030; CAA26833.1; -; mRNA.
DR   PIR; A24302; PHRBG.
DR   RefSeq; NP_001075653.1; -.
DR   UniGene; Ocu.2087; -.
DR   PDB; 1A8I; X-ray; 1.78 A; A=1-843.
DR   PDB; 1ABB; X-ray; 2.80 A; A/B/C/D=11-838.
DR   PDB; 1AXR; X-ray; 2.30 A; A=1-843.
DR   PDB; 1B4D; X-ray; 2.00 A; A=1-843.
DR   PDB; 1BX3; X-ray; 2.30 A; A=1-843.
DR   PDB; 1C50; X-ray; 2.30 A; A=14-843.
DR   PDB; 1C8K; X-ray; 1.76 A; A=1-843.
DR   PDB; 1C8L; X-ray; 2.30 A; A=1-843.
DR   PDB; 1E1Y; X-ray; 2.23 A; A=1-843.
DR   PDB; 1FS4; X-ray; 2.38 A; A=1-843.
DR   PDB; 1FTQ; X-ray; 2.35 A; A=1-843.
DR   PDB; 1FTW; X-ray; 2.36 A; A=1-843.
DR   PDB; 1FTY; X-ray; 2.38 A; A=1-843.
DR   PDB; 1FU4; X-ray; 2.36 A; A=1-843.
DR   PDB; 1FU7; X-ray; 2.36 A; A=1-843.
DR   PDB; 1FU8; X-ray; 2.35 A; A=1-843.
DR   PDB; 1GFZ; X-ray; 2.30 A; A=1-843.
DR   PDB; 1GG8; X-ray; 2.31 A; A=1-843.
DR   PDB; 1GGN; X-ray; 2.36 A; A=1-843.
DR   PDB; 1GPA; X-ray; 2.90 A; A/B/C/D=1-843.
DR   PDB; 1GPB; X-ray; 1.90 A; A=1-843.
DR   PDB; 1GPY; X-ray; 2.40 A; A=1-843.
DR   PDB; 1H5U; X-ray; 1.76 A; A=1-843.
DR   PDB; 1HLF; X-ray; 2.26 A; A=1-843.
DR   PDB; 1K06; X-ray; 1.80 A; A=1-843.
DR   PDB; 1K08; X-ray; 2.26 A; A=1-843.
DR   PDB; 1KTI; X-ray; 1.97 A; A=1-843.
DR   PDB; 1LWN; X-ray; 2.00 A; A=1-843.
DR   PDB; 1LWO; X-ray; 2.00 A; A=1-843.
DR   PDB; 1NOI; X-ray; 2.50 A; A/B/C/D=2-843.
DR   PDB; 1NOJ; X-ray; 2.40 A; A=1-843.
DR   PDB; 1NOK; X-ray; 2.40 A; A=1-843.
DR   PDB; 1P29; X-ray; 2.20 A; A=1-843.
DR   PDB; 1P2B; X-ray; 2.20 A; A=1-843.
DR   PDB; 1P2D; X-ray; 1.94 A; A=1-843.
DR   PDB; 1P2G; X-ray; 2.30 A; A=1-843.
DR   PDB; 1P4G; X-ray; 2.10 A; A=1-843.
DR   PDB; 1P4H; X-ray; 2.06 A; A=1-843.
DR   PDB; 1P4J; X-ray; 2.00 A; A=1-843.
DR   PDB; 1PYG; X-ray; 2.87 A; A/B/C/D=1-843.
DR   PDB; 1UZU; X-ray; 2.30 A; A=1-843.
DR   PDB; 1WUT; X-ray; 2.26 A; A=1-843.
DR   PDB; 1WUY; X-ray; 2.26 A; A=1-843.
DR   PDB; 1WV0; X-ray; 2.26 A; A=1-843.
DR   PDB; 1WV1; X-ray; 2.26 A; A=1-843.
DR   PDB; 1WW2; X-ray; 1.90 A; A=1-843.
DR   PDB; 1WW3; X-ray; 1.80 A; A=1-843.
DR   PDB; 1XC7; X-ray; 1.83 A; A=1-843.
DR   PDB; 1XKX; X-ray; 1.93 A; A=1-843.
DR   PDB; 1XL0; X-ray; 1.92 A; A=1-843.
DR   PDB; 1XL1; X-ray; 2.10 A; A=1-843.
DR   PDB; 1Z62; X-ray; 1.90 A; A=1-843.
DR   PDB; 1Z6P; X-ray; 2.40 A; A=1-843.
DR   PDB; 1Z6Q; X-ray; 2.03 A; A=1-843.
DR   PDB; 2AMV; X-ray; 2.30 A; A=1-843.
DR   PDB; 2F3P; X-ray; 1.94 A; A=2-843.
DR   PDB; 2F3Q; X-ray; 1.96 A; A=2-843.
DR   PDB; 2F3S; X-ray; 1.96 A; A=2-843.
DR   PDB; 2F3U; X-ray; 1.93 A; A=1-843.
DR   PDB; 2FET; X-ray; 2.03 A; A=2-843.
DR   PDB; 2FF5; X-ray; 2.03 A; A=2-843.
DR   PDB; 2FFR; X-ray; 2.03 A; A=13-837.
DR   PDB; 2G9Q; X-ray; 2.50 A; A=2-843.
DR   PDB; 2G9R; X-ray; 2.07 A; A=2-843.
DR   PDB; 2G9U; X-ray; 2.15 A; A=2-843.
DR   PDB; 2G9V; X-ray; 2.15 A; A=2-843.
DR   PDB; 2GJ4; X-ray; 1.60 A; A=13-836.
DR   PDB; 2GM9; X-ray; 2.30 A; A=13-837.
DR   PDB; 2GPA; X-ray; 2.00 A; A=1-843.
DR   PDB; 2GPB; X-ray; 2.30 A; A=1-843.
DR   PDB; 2GPN; X-ray; 1.99 A; A=1-843.
DR   PDB; 2IEG; X-ray; 1.90 A; A/B=2-843.
DR   PDB; 2IEI; X-ray; 1.91 A; A/B=2-843.
DR   PDB; 2OFF; X-ray; 2.20 A; A=2-843.
DR   PDB; 2PRI; X-ray; 2.30 A; A=1-843.
DR   PDB; 2PRJ; X-ray; 2.30 A; A=1-843.
DR   PDB; 2SKC; X-ray; 2.40 A; A=1-843.
DR   PDB; 2SKD; X-ray; 2.40 A; A=1-843.
DR   PDB; 2SKE; X-ray; 2.46 A; A=1-843.
DR   PDB; 3AMV; X-ray; 2.10 A; A=1-843.
DR   PDB; 3GPB; X-ray; 2.30 A; A=1-843.
DR   PDB; 4GPB; X-ray; 2.30 A; A=1-843.
DR   PDB; 5GPB; X-ray; 2.30 A; A=1-843.
DR   PDB; 6GPB; X-ray; 2.86 A; A=1-843.
DR   PDB; 7GPB; X-ray; 2.90 A; A/B/C/D=1-843.
DR   PDB; 8GPB; X-ray; 2.20 A; A=1-843.
DR   PDB; 9GPB; X-ray; 2.90 A; A/B/C/D=1-843.
DR   PDBsum; 1A8I; -.
DR   PDBsum; 1ABB; -.
DR   PDBsum; 1AXR; -.
DR   PDBsum; 1B4D; -.
DR   PDBsum; 1BX3; -.
DR   PDBsum; 1C50; -.
DR   PDBsum; 1C8K; -.
DR   PDBsum; 1C8L; -.
DR   PDBsum; 1E1Y; -.
DR   PDBsum; 1FS4; -.
DR   PDBsum; 1FTQ; -.
DR   PDBsum; 1FTW; -.
DR   PDBsum; 1FTY; -.
DR   PDBsum; 1FU4; -.
DR   PDBsum; 1FU7; -.
DR   PDBsum; 1FU8; -.
DR   PDBsum; 1GFZ; -.
DR   PDBsum; 1GG8; -.
DR   PDBsum; 1GGN; -.
DR   PDBsum; 1GPA; -.
DR   PDBsum; 1GPB; -.
DR   PDBsum; 1GPY; -.
DR   PDBsum; 1H5U; -.
DR   PDBsum; 1HLF; -.
DR   PDBsum; 1K06; -.
DR   PDBsum; 1K08; -.
DR   PDBsum; 1KTI; -.
DR   PDBsum; 1LWN; -.
DR   PDBsum; 1LWO; -.
DR   PDBsum; 1NOI; -.
DR   PDBsum; 1NOJ; -.
DR   PDBsum; 1NOK; -.
DR   PDBsum; 1P29; -.
DR   PDBsum; 1P2B; -.
DR   PDBsum; 1P2D; -.
DR   PDBsum; 1P2G; -.
DR   PDBsum; 1P4G; -.
DR   PDBsum; 1P4H; -.
DR   PDBsum; 1P4J; -.
DR   PDBsum; 1PYG; -.
DR   PDBsum; 1UZU; -.
DR   PDBsum; 1WUT; -.
DR   PDBsum; 1WUY; -.
DR   PDBsum; 1WV0; -.
DR   PDBsum; 1WV1; -.
DR   PDBsum; 1WW2; -.
DR   PDBsum; 1WW3; -.
DR   PDBsum; 1XC7; -.
DR   PDBsum; 1XKX; -.
DR   PDBsum; 1XL0; -.
DR   PDBsum; 1XL1; -.
DR   PDBsum; 1Z62; -.
DR   PDBsum; 1Z6P; -.
DR   PDBsum; 1Z6Q; -.
DR   PDBsum; 2AMV; -.
DR   PDBsum; 2F3P; -.
DR   PDBsum; 2F3Q; -.
DR   PDBsum; 2F3S; -.
DR   PDBsum; 2F3U; -.
DR   PDBsum; 2FET; -.
DR   PDBsum; 2FF5; -.
DR   PDBsum; 2FFR; -.
DR   PDBsum; 2G9Q; -.
DR   PDBsum; 2G9R; -.
DR   PDBsum; 2G9U; -.
DR   PDBsum; 2G9V; -.
DR   PDBsum; 2GJ4; -.
DR   PDBsum; 2GM9; -.
DR   PDBsum; 2GPA; -.
DR   PDBsum; 2GPB; -.
DR   PDBsum; 2GPN; -.
DR   PDBsum; 2IEG; -.
DR   PDBsum; 2IEI; -.
DR   PDBsum; 2OFF; -.
DR   PDBsum; 2PRI; -.
DR   PDBsum; 2PRJ; -.
DR   PDBsum; 2SKC; -.
DR   PDBsum; 2SKD; -.
DR   PDBsum; 2SKE; -.
DR   PDBsum; 3AMV; -.
DR   PDBsum; 3GPB; -.
DR   PDBsum; 4GPB; -.
DR   PDBsum; 5GPB; -.
DR   PDBsum; 6GPB; -.
DR   PDBsum; 7GPB; -.
DR   PDBsum; 8GPB; -.
DR   PDBsum; 9GPB; -.
DR   GeneID; 100008972; -.
DR   HOVERGEN; P00489; -.
DR   DrugBank; DB00131; Adenosine monophosphate.
DR   LinkHub; P00489; -.
DR   InterPro; IPR011833; Glycg_phsphrylas.
DR   InterPro; IPR000811; Glyco_trans_35.
DR   PANTHER; PTHR11468; Glyco_trans_35; 1.
DR   Pfam; PF00343; Phosphorylase; 1.
DR   PIRSF; PIRSF000460; Pprylas_GlgP; 1.
DR   TIGRFAMs; TIGR02093; P_ylase; 1.
DR   PROSITE; PS00102; PHOSPHORYLASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; Carbohydrate metabolism;
KW   Direct protein sequencing; Glycogen metabolism; Glycosyltransferase;
KW   Nucleotide-binding; Phosphoprotein; Pyridoxal phosphate; Transferase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    843       Glycogen phosphorylase, muscle form.
FT                                /FTId=PRO_0000188532.
FT   BINDING      76     76       AMP.
FT   BINDING     681    681       Pyridoxal phosphate (covalent).
FT   SITE        109    109       Involved in the association of subunits.
FT   SITE        143    143       Involved in the association of subunits.
FT   SITE        156    156       Can be labeled by an AMP analog; may be
FT                                involved in allosteric regulation.
FT   MOD_RES       2      2       N-acetylserine.
FT   MOD_RES      15     15       Phosphoserine; by PHK; in form
FT                                phosphorylase A.
FT   MOD_RES     473    473       Phosphotyrosine (By similarity).
FT   CONFLICT     31     33       NFN -> DFD (in Ref. 2; AA sequence).
FT   CONFLICT     43     43       D -> N (in Ref. 2; AA sequence).
FT   CONFLICT     56     58       LAH -> HAL (in Ref. 2; AA sequence).
FT   CONFLICT     89     89       E -> Q (in Ref. 2; AA sequence).
FT   CONFLICT    113    113       T -> D (in Ref. 2; AA sequence).
FT   CONFLICT    309    309       Missing (in Ref. 2; AA sequence).
FT   CONFLICT    578    579       LL -> FF (in Ref. 6; CAA26833).
FT   CONFLICT    610    610       A -> P (in Ref. 1; BAA00027/CAA27816).
FT   CONFLICT    713    713       G -> C (in Ref. 6; CAA26833).
FT   HELIX         9     13
FT   HELIX        15     17
FT   HELIX        22     38
FT   TURN         44     46
FT   HELIX        49     78
FT   STRAND       82     86
FT   STRAND       90     93
FT   HELIX        96    102
FT   HELIX       106    115
FT   HELIX       120    124
FT   STRAND      130    133
FT   HELIX       136    150
FT   STRAND      155    160
FT   STRAND      168    172
FT   STRAND      175    179
FT   TURN        183    186
FT   HELIX       195    197
FT   STRAND      199    204
FT   STRAND      206    210
FT   STRAND      213    218
FT   STRAND      220    232
FT   STRAND      234    236
FT   STRAND      239    248
FT   HELIX       263    268
FT   HELIX       270    274
FT   HELIX       275    277
FT   HELIX       291    313
FT   HELIX       325    328
FT   HELIX       330    333
FT   STRAND      334    341
FT   TURN        342    345
FT   HELIX       346    356
FT   HELIX       362    372
FT   STRAND      373    376
FT   HELIX       382    384
FT   STRAND      387    389
FT   HELIX       390    396
FT   HELIX       398    418
FT   HELIX       423    429
FT   STRAND      431    433
FT   STRAND      435    437
FT   STRAND      439    441
FT   HELIX       442    448
FT   STRAND      451    457
FT   HELIX       458    466
FT   TURN        467    469
FT   HELIX       470    475
FT   HELIX       477    479
FT   STRAND      480    482
FT   HELIX       490    495
FT   HELIX       498    508
FT   HELIX       511    514
FT   HELIX       516    525
FT   HELIX       529    554
FT   STRAND      560    569
FT   HELIX       573    575
FT   HELIX       577    593
FT   STRAND      602    607
FT   HELIX       615    631
FT   TURN        635    639
FT   STRAND      640    646
FT   HELIX       651    657
FT   HELIX       658    660
FT   STRAND      662    666
FT   HELIX       678    684
FT   STRAND      688    691
FT   HELIX       697    704
FT   HELIX       706    708
FT   STRAND      709    711
FT   HELIX       716    725
FT   HELIX       729    735
FT   HELIX       737    747
FT   TURN        748    751
FT   TURN        756    759
FT   HELIX       760    768
FT   HELIX       774    777
FT   HELIX       778    792
FT   HELIX       795    806
FT   HELIX       810    812
FT   HELIX       814    824
SQ   SEQUENCE   843 AA;  97289 MW;  9884F06FDD3AE9D3 CRC64;
     MSRPLSDQEK RKQISVRGLA GVENVTELKK NFNRHLHFTL VKDRNVATPR DYYFALAHTV
     RDHLVGRWIR TQQHYYEKDP KRIYYLSLEF YMGRTLQNTM VNLALENACD EATYQLGLDM
     EELEEIEEDA GLGNGGLGRL AACFLDSMAT LGLAAYGYGI RYEFGIFNQK ICGGWQMEEA
     DDWLRYGNPW EKARPEFTLP VHFYGRVEHT SQGAKWVDTQ VVLAMPYDTP VPGYRNNVVN
     TMRLWSAKAP NDFNLKDFNV GGYIQAVLDR NLAENISRVL YPNDNFFEGK ELRLKQEYFV
     VAATLQDIIR RFKSSKFGCR DPVRTNFDAF PDKVAIQLND THPSLAIPEL MRVLVDLERL
     DWDKAWEVTV KTCAYTNHTV LPEALERWPV HLLETLLPRH LQIIYEINQR FLNRVAAAFP
     GDVDRLRRMS LVEEGAVKRI NMAHLCIAGS HAVNGVARIH SEILKKTIFK DFYELEPHKF
     QNKTNGITPR RWLVLCNPGL AEIIAERIGE EYISDLDQLR KLLSYVDDEA FIRDVAKVKQ
     ENKLKFAAYL EREYKVHINP NSLFDVQVKR IHEYKRQLLN CLHVITLYNR IKKEPNKFVV
     PRTVMIGGKA APGYHMAKMI IKLITAIGDV VNHDPVVGDR LRVIFLENYR VSLAEKVIPA
     ADLSEQISTA GTEASGTGNM KFMLNGALTI GTMDGANVEM AEEAGEENFF IFGMRVEDVD
     RLDQRGYNAQ EYYDRIPELR QIIEQLSSGF FSPKQPDLFK DIVNMLMHHD RFKVFADYEE
     YVKCQERVSA LYKNPREWTR MVIRNIATSG KFSSDRTIAQ YAREIWGVEP SRQRLPAPDE
     KIP
//
ID   PERL_BOVIN              Reviewed;         712 AA.
AC   P80025;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   10-JUN-2008, entry version 86.
DE   Lactoperoxidase precursor (EC 1.11.1.7) (LPO).
GN   Name=LPO;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   MEDLINE=91025552; PubMed=2222811;
RA   Dull T.J., Uyeda C., Strosberg A.D., Nedwin G., Seilhamer J.J.;
RT   "Molecular cloning of cDNAs encoding bovine and human
RT   lactoperoxidase.";
RL   DNA Cell Biol. 9:499-509(1990).
RN   [2]
RP   PROTEIN SEQUENCE OF 101-712.
RC   TISSUE=Milk;
RX   MEDLINE=91266958; PubMed=2050150;
RA   Cals M.-M., Mailliart P., Brignon G., Anglade P., Ribadeau-Dumas B.;
RT   "Primary structure of bovine lactoperoxidase, a fourth member of a
RT   mammalian heme peroxidase family.";
RL   Eur. J. Biochem. 198:733-739(1991).
RN   [3]
RP   CIRCULAR DICHROISM ANALYSIS, AND PARTIAL PROTEIN SEQUENCE.
RX   MEDLINE=20384171; PubMed=10924350; DOI=10.1006/bbrc.2000.3217;
RA   Watanabe S., Murata S., Kumura H., Nakamura S., Bollen A.,
RA   Moguilevsky N., Shimazaki K.;
RT   "Bovine lactoperoxidase and its recombinant: comparison of structure
RT   and some biochemical properties.";
RL   Biochem. Biophys. Res. Commun. 274:756-761(2000).
RN   [4]
RP   COVALENT HEME ATTACHMENT.
RX   MEDLINE=97238804; PubMed=9083001; DOI=10.1074/jbc.272.14.8857;
RA   DePillis G.D., Ozaki S., Kuo J.M., Maltby D.A.,
RA   Ortiz de Montellano P.R.;
RT   "Autocatalytic processing of heme by lactoperoxidase produces the
RT   native protein-bound prosthetic group.";
RL   J. Biol. Chem. 272:8857-8860(1997).
RN   [5]
RP   COVALENT HEME ATTACHMENT.
RC   TISSUE=Milk;
RX   MEDLINE=98447642; PubMed=9774411; DOI=10.1074/jbc.273.43.27968;
RA   Rae T.D., Goff H.M.;
RT   "The heme prosthetic group of lactoperoxidase. Structural
RT   characteristics of heme l and heme l-peptides.";
RL   J. Biol. Chem. 273:27968-27977(1998).
RN   [6]
RP   COVALENT HEME ATTACHMENT, AND MUTAGENESIS OF ASP-225 AND GLU-375.
RX   MEDLINE=21481384; PubMed=11597409; DOI=10.1016/S0960-894X(01)00533-9;
RA   Suriano G., Watanabe S., Ghibaudi E.M., Bollen A., Ferrari R.P.,
RA   Moguilevsky N.;
RT   "Glu375Gln and Asp225Val mutants: about the nature of the covalent
RT   linkages between heme group and apo-protein in bovine
RT   lactoperoxidase.";
RL   Bioorg. Med. Chem. Lett. 11:2827-2831(2001).
RN   [7]
RP   COVALENT HEME ATTACHMENT, AND MUTAGENESIS OF ASP-225 AND GLU-375.
RX   MEDLINE=21850707; PubMed=11756449; DOI=10.1074/jbc.M109523200;
RA   Colas C., Kuo J.M., Ortiz de Montellano P.R.;
RT   "Asp-225 and Glu-375 in autocatalytic attachment of the prosthetic
RT   heme group of lactoperoxidase.";
RL   J. Biol. Chem. 277:7191-7200(2002).
CC   -!- FUNCTION: LPO is an antimicrobial agent. It is thought to help
CC       protect the udder from infection and promote growth in newborn
CC       calves.
CC   -!- CATALYTIC ACTIVITY: Donor + H(2)O(2) = oxidized donor + 2 H(2)O.
CC   -!- COFACTOR: Binds 1 calcium ion per heterodimer (By similarity).
CC   -!- COFACTOR: Binds 1 heme B (iron-protoporphyrin IX) group covalently
CC       per heterodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space.
CC   -!- TISSUE SPECIFICITY: Mammary gland; milk.
CC   -!- SIMILARITY: Belongs to the peroxidase family. XPO subfamily.
CC   -!- WEB RESOURCE: Name=Worthington enzyme manual;
CC       URL="http://www.worthington-biochem.com/LPO/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M58150; AAA62714.1; -; mRNA.
DR   PIR; A35828; A35828.
DR   RefSeq; NP_776358.1; -.
DR   UniGene; Bt.4784; -.
DR   PDB; 2GJ1; X-ray; 2.30 A; A=130-712.
DR   PDB; 2IPS; X-ray; 3.10 A; A=118-712.
DR   PDB; 2NQX; X-ray; 2.95 A; A=118-712.
DR   PDB; 2O86; X-ray; 2.80 A; A=118-712.
DR   PDB; 2PT3; X-ray; 2.34 A; A=118-712.
DR   PDB; 2PUM; X-ray; 2.70 A; A=118-712.
DR   PDB; 2QPK; X-ray; 2.34 A; A=118-712.
DR   PDB; 2QQT; X-ray; 2.50 A; A=118-712.
DR   PDB; 2QRB; X-ray; 2.50 A; A=118-712.
DR   PDBsum; 2GJ1; -.
DR   PDBsum; 2IPS; -.
DR   PDBsum; 2NQX; -.
DR   PDBsum; 2O86; -.
DR   PDBsum; 2PT3; -.
DR   PDBsum; 2PUM; -.
DR   PDBsum; 2QPK; -.
DR   PDBsum; 2QQT; -.
DR   PDBsum; 2QRB; -.
DR   PeroxiBase; 3331; BtLPO.
DR   Ensembl; ENSBTAG00000012780; Bos taurus.
DR   GeneID; 280844; -.
DR   KEGG; bta:280844; -.
DR   HOVERGEN; P80025; -.
DR   InterPro; IPR002007; Haem_peroxidase_animal.
DR   InterPro; IPR002016; Haem_peroxidase_pln/fun/bac.
DR   Gene3D; G3DSA:1.10.640.10; Haem_peroxidase_animal; 1.
DR   Pfam; PF03098; An_peroxidase; 1.
DR   PRINTS; PR00457; ANPEROXIDASE.
DR   PROSITE; PS00435; PEROXIDASE_1; FALSE_NEG.
DR   PROSITE; PS00436; PEROXIDASE_2; FALSE_NEG.
DR   PROSITE; PS50292; PEROXIDASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic; Antimicrobial; Calcium;
KW   Cleavage on pair of basic residues; Direct protein sequencing;
KW   Glycoprotein; Heme; Hydrogen peroxide; Iron; Metal-binding;
KW   Oxidoreductase; Peroxidase; Secreted; Signal.
FT   SIGNAL        1     22       Potential.
FT   PROPEP       23    100
FT                                /FTId=PRO_0000023647.
FT   CHAIN       101    712       Lactoperoxidase.
FT                                /FTId=PRO_0000023648.
FT   ACT_SITE    226    226       Proton acceptor (By similarity).
FT   METAL       227    227       Calcium (By similarity).
FT   METAL       301    301       Calcium (By similarity).
FT   METAL       303    303       Calcium (via carbonyl oxygen) (By
FT                                similarity).
FT   METAL       305    305       Calcium (By similarity).
FT   METAL       307    307       Calcium (By similarity).
FT   METAL       468    468       Iron (heme axial ligand) (By similarity).
FT   BINDING     225    225       Heme (covalent; via 2 links).
FT   BINDING     375    375       Heme (covalent; via 2 links).
FT   SITE        372    372       Transition state stabilizer (By
FT                                similarity).
FT   CARBOHYD    106    106       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    212    212       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    322    322       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    358    358       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    449    449       N-linked (GlcNAc...) (Potential).
FT   DISULFID    132    145       By similarity.
FT   DISULFID    246    256       By similarity.
FT   DISULFID    250    274       By similarity.
FT   DISULFID    354    365       By similarity.
FT   DISULFID    573    630       By similarity.
FT   DISULFID    671    696       By similarity.
FT   VARIANT     394    394       A -> S.
FT   MUTAGEN     225    225       D->E: Partially bound heme and decrease
FT                                in activity. Loss of heme binding and
FT                                activity; when associated with D-375.
FT   MUTAGEN     225    225       D->V: Partially bound heme.
FT   MUTAGEN     375    375       E->D: Partially bound heme. Loss of heme
FT                                binding and activity; when associated
FT                                with E-225.
FT   MUTAGEN     375    375       E->Q: Decrease in activity.
FT   CONFLICT    449    449       N -> R (in Ref. 2; AA sequence).
FT   STRAND      141    143
FT   STRAND      146    150
FT   TURN        151    154
FT   STRAND      156    159
FT   STRAND      171    173
FT   HELIX       192    199
FT   STRAND      209    214
FT   HELIX       215    228
FT   HELIX       242    245
FT   TURN        246    249
FT   HELIX       266    270
FT   STRAND      273    275
FT   STRAND      282    284
FT   STRAND      296    298
FT   STRAND      302    305
FT   HELIX       307    310
FT   HELIX       314    320
FT   HELIX       353    356
FT   TURN        359    361
FT   TURN        371    374
FT   HELIX       377    400
FT   HELIX       406    427
FT   TURN        428    430
FT   HELIX       431    434
FT   HELIX       435    437
FT   HELIX       438    441
FT   HELIX       460    463
FT   HELIX       464    470
FT   STRAND      473    476
FT   STRAND      490    492
FT   HELIX       493    496
FT   HELIX       501    504
FT   TURN        505    507
FT   HELIX       510    518
FT   STRAND      519    522
FT   HELIX       532    535
FT   STRAND      546    548
FT   HELIX       550    560
FT   HELIX       566    572
FT   HELIX       581    588
FT   HELIX       591    601
FT   HELIX       604    606
FT   HELIX       609    614
FT   STRAND      622    624
FT   HELIX       626    641
FT   HELIX       655    661
FT   HELIX       666    673
FT   TURN        689    692
FT   HELIX       696    698
FT   HELIX       705    707
SQ   SEQUENCE   712 AA;  80642 MW;  28EED4C0C8420E6D CRC64;
     MWVCLQLPVF LASVTLFEVA ASDTIAQAAS TTTISDAVSK VKIQVNKAFL DSRTRLKTTL
     SSEAPTTQQL SEYFKHAKGR TRTAIRNGQV WEESLKRLRR DTTLTNVTDP SLDLTALSWE
     VGCGAPVPLV KCDENSPYRT ITGDCNNRRS PALGAANRAL ARWLPAEYED GLALPFGWTQ
     RKTRNGFRVP LAREVSNKIV GYLDEEGVLD QNRSLLFMQW GQIVDHDLDF APETELGSNE
     HSKTQCEEYC IQGDNCFPIM FPKNDPKLKT QGKCMPFFRA GFVCPTPPYQ SLAREQINAV
     TSFLDASLVY GSEPSLASRL RNLSSPLGLM AVNQEAWDHG LAYLPFNNKK PSPCEFINTT
     ARVPCFLAGD FRASEQILLA TAHTLLLREH NRLARELKKL NPHWNGEKLY QEARKILGAF
     IQIITFRDYL PIVLGSEMQK WIPPYQGYNN SVDPRISNVF TFAFRFGHME VPSTVSRLDE
     NYQPWGPEAE LPLHTLFFNT WRIIKDGGID PLVRGLLAKK SKLMNQDKMV TSELRNKLFQ
     PTHKIHGFDL AAINLQRCRD HGMPGYNSWR GFCGLSQPKT LKGLQTVLKN KILAKKLMDL
     YKTPDNIDIW IGGNAEPMVE RGRVGPLLAC LLGRQFQQIR DGDRFWWENP GVFTEKQRDS
     LQKVSFSRLI CDNTHITKVP LHAFQANNYP HDFVDCSTVD KLDLSPWASR EN
//
ID   PYGM_HUMAN              Reviewed;         842 AA.
AC   P11217; A0AVK1;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 6.
DT   10-JUN-2008, entry version 109.
DE   Glycogen phosphorylase, muscle form (EC 2.4.1.1) (Myophosphorylase).
GN   Name=PYGM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=88190078; PubMed=3447177; DOI=10.1002/prot.340020303;
RA   Burke J., Hwang P.K., Anderson L., Lebo R., Gorin F., Fletterick R.J.;
RT   "Intron/exon structure of the human gene for the muscle isozyme of
RT   glycogen phosphorylase.";
RL   Proteins 2:177-187(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9633816;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:1<27::AID-HUMU4>3.0.CO;2-#;
RA   Kubisch C., Wicklein E.M., Jentsch T.J.;
RT   "Molecular diagnosis of McArdle disease: revised genomic structure of
RT   the myophosphorylase gene and identification of a novel mutation.";
RL   Hum. Mutat. 12:27-32(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Muscle;
RA   Carty M.D., Clancy Y.C., Soeller W.C.;
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 676-842.
RX   MEDLINE=86030264; PubMed=3840433;
RA   Hwang P.K., See Y.P., Vincentini A.M., Powers M.A., Fletterick R.J.,
RA   Crerar M.M.;
RT   "Comparative sequence analysis of rat, rabbit, and human muscle
RT   glycogen phosphorylase cDNAs.";
RL   Eur. J. Biochem. 152:267-274(1985).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 455-676.
RX   MEDLINE=87083949; PubMed=3466902;
RA   Gautron S., Daegelen D., Mennecier F., Dubocq D., Kahn A.,
RA   Dreyfus J.-C.;
RT   "Molecular mechanisms of McArdle's disease (muscle glycogen
RT   phosphorylase deficiency). RNA and DNA analysis.";
RL   J. Clin. Invest. 79:275-281(1987).
RN   [7]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=1150650;
RA   Carty T.J., Tu J., Graves D.J.;
RT   "Regulation of glycogen phosphorylase. Role of the peptide region
RT   surrounding the phosphoserine residue in determining enzyme
RT   properties.";
RL   J. Biol. Chem. 250:4980-4985(1975).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15, AND MASS
RP   SPECTROMETRY.
RX   PubMed=16083285; DOI=10.1021/pr050048h;
RA   Kim J.-E., Tannenbaum S.R., White F.M.;
RT   "Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
RL   J. Proteome Res. 4:1339-1346(2005).
RN   [9]
RP   VARIANTS GSD5 SER-205 AND THR-543.
RX   MEDLINE=93302817; PubMed=8316268; DOI=10.1056/NEJM199307223290404;
RA   Tsujino S., Shanske S., Dimauro S.;
RT   "Molecular genetic heterogeneity of myophosphorylase deficiency
RT   (McArdle's disease).";
RL   N. Engl. J. Med. 329:241-245(1993).
RN   [10]
RP   VARIANTS GSD5 PRO-397 AND LYS-655.
RX   MEDLINE=96121625; PubMed=8535454;
RA   Tsujino S., Shanske S., Martinuzzi A., Heiman-Patterson T.,
RA   Dimauro S.;
RT   "Two novel missense mutations (E654K, L396P) in Caucasian patients
RT   with myophosphorylase deficiency (McArdle's disease).";
RL   Hum. Mutat. 6:276-277(1995).
RN   [11]
RP   VARIANTS GSD5 SER-205; PRO-292; PRO-397; THR-543; LYS-655 AND PHE-709
RP   DEL.
RX   MEDLINE=95327145; PubMed=7603523; DOI=10.1002/mus.880181407;
RA   Tsujino S., Shanske S., Nonaka I., DiMauro S.;
RT   "The molecular genetic basis of myophosphorylase deficiency (McArdle's
RT   disease).";
RL   Muscle Nerve 3:S23-S27(1995).
RN   [12]
RP   VARIANTS GSD5 GLU-666 AND ARG-686.
RX   MEDLINE=98165374; PubMed=9506549;
RA   Vorgerd M., Kubisch C., Burwinkel B., Reichmann H., Mortier W.,
RA   Tettenborn B., Pongratz D., Lindemuth R., Tegenthoff M., Malin J.P.,
RA   Kilimann M.W.;
RT   "Mutation analysis in myophosphorylase deficiency (McArdle's
RT   disease).";
RL   Ann. Neurol. 43:326-331(1998).
RN   [13]
RP   VARIANT GSD5 PRO-116.
RX   MEDLINE=21059984; PubMed=10417800;
RX   DOI=10.1002/(SICI)1097-4598(199908)22:8<1136::AID-MUS21>3.0.CO;2-2;
RA   Gamez J., Fernandez R., Bruno C., Andreu A.L., Cervera C., Navarro C.,
RA   Schwartz S., Dimauro S.;
RT   "A new mutation in the regulatory domain of the myophosphorylase gene
RT   affecting protein dimer contact.";
RL   Muscle Nerve 22:1136-1138(1999).
RN   [14]
RP   VARIANTS GSD5 SER-205 AND TYR-685.
RX   MEDLINE=99310284; PubMed=10382911; DOI=10.1016/S0960-8966(98)00125-4;
RA   Andreu A.L., Bruno C., Tamburino L., Gamez J., Shanske S., Cervera C.,
RA   Navarro C., DiMauro S.;
RT   "A new mutation in the myophosphorylase gene (Asn684Tyr) in a Spanish
RT   patient with McArdle's disease.";
RL   Neuromuscul. Disord. 9:171-173(1999).
RN   [15]
RP   VARIANT GSD5 SER-205.
RX   MEDLINE=99310285; PubMed=10382912; DOI=10.1016/S0960-8966(98)00127-8;
RA   Rubio J.C., Martin M.A., Garcia A., Campos Y., Cabello A.,
RA   Culebras J.M., Arenas J.;
RT   "McArdle's disease associated with homozygosity for the missense
RT   mutation Gly204Ser of the myophosphorylase gene in a Spanish
RT   patient.";
RL   Neuromuscul. Disord. 9:174-175(1999).
RN   [16]
RP   VARIANT GSD5 ARG-798.
RX   MEDLINE=20143315; PubMed=10681080; DOI=10.1001/archneur.57.2.217;
RA   Fernandez R., Navarro C., Andreu A.L., Bruno C., Shanske S., Gamez J.,
RA   Teijeira S., Hernandez I., Teijeiro A., Fernandez J.M., Musumeci O.,
RA   DiMauro S.;
RT   "A novel missense mutation (W797R) in the myophosphorylase gene in
RT   Spanish patients with McArdle disease.";
RL   Arch. Neurol. 57:217-219(2000).
RN   [17]
RP   VARIANT GSD5 ARG-798.
RX   MEDLINE=20059849; PubMed=10590419;
RX   DOI=10.1002/(SICI)1097-4598(200001)23:1<129::AID-MUS20>3.0.CO;2-F;
RA   Rubio J.C., Martin M.A., Campos Y., Auciello R., Cabello A.,
RA   Arenas J.;
RT   "A missense mutation W797R in the myophosphorylase gene in a Spanish
RT   patient with McArdle's disease.";
RL   Muscle Nerve 23:129-131(2000).
RN   [18]
RP   VARIANT GSD5 ASN-488.
RX   MEDLINE=20177049; PubMed=10714589; DOI=10.1016/S0960-8966(99)00082-6;
RA   Rubio J.C., Martin M.A., Campos Y., Cabello A., Arenas J.;
RT   "A missense mutation T487N in the myophosphorylase gene in a Spanish
RT   patient with McArdle's disease.";
RL   Neuromuscul. Disord. 10:138-140(2000).
RN   [19]
RP   VARIANT GSD5 ASP-660.
RX   MEDLINE=20359172; PubMed=10899452; DOI=10.1016/S0960-8966(99)00124-8;
RA   Martin M.A., Rubio J.C., Campos Y., Ricoy J.R., Cabello A., Arenas J.;
RT   "A homozygous missense mutation (A659D) in the myophosphorylase gene
RT   in a Spanish patient with McArdle's disease.";
RL   Neuromuscul. Disord. 10:447-449(2000).
RN   [20]
RP   VARIANTS GSD5 PRO-116; TRP-194; SER-205; LYS-349; ASN-488; TRP-602;
RP   ASP-660; TYR-685; VAL-704 AND ARG-798.
RX   MEDLINE=21563342; PubMed=11706962; DOI=10.1002/ana.1225.abs;
RA   Martin M.A., Rubio J.C., Buchbinder J., Fernandez-Hojas R.,
RA   del Hoyo P., Teijeira S., Gamez J., Navarro C., Fernandez J.M.,
RA   Cabello A., Campos Y., Cervera C., Culebras J.M., Andreu A.L.,
RA   Fletterick R.J., Arenas J.;
RT   "Molecular heterogeneity of myophosphorylase deficiency (McArdle's
RT   disease): a genotype-phenotype correlation study.";
RL   Ann. Neurol. 50:574-581(2001).
RN   [21]
RP   VARIANT GSD5 PRO-687.
RX   MEDLINE=22028668; PubMed=12031624; DOI=10.1016/S0960-8966(01)00320-0;
RA   Bruno C., Lanzillo R., Biedi C., Iadicicco L., Minetti C., Santoro L.;
RT   "Two new mutations in the myophosphorylase gene in Italian patients
RT   with McArdle's disease.";
RL   Neuromuscul. Disord. 12:498-500(2002).
CC   -!- FUNCTION: Phosphorylase is an important allosteric enzyme in
CC       carbohydrate metabolism. Enzymes from different sources differ in
CC       their regulatory mechanisms and in their natural substrates.
CC       However, all known phosphorylases share catalytic and structural
CC       properties.
CC   -!- CATALYTIC ACTIVITY: (1,4-alpha-D-glucosyl)(n) + phosphate = (1,4-
CC       alpha-D-glucosyl)(n-1) + alpha-D-glucose 1-phosphate.
CC   -!- COFACTOR: Pyridoxal phosphate.
CC   -!- ENZYME REGULATION: Activity of phosphorylase is controlled both by
CC       allosteric means (through the noncovalent binding of metabolites)
CC       and by covalent modification. Thus AMP allosterically activates,
CC       whereas ATP, ADP, and glucose-6-phosphate allosterically inhibit,
CC       phosphorylase B.
CC   -!- SUBUNIT: Homodimer. Dimers associate into a tetramer to form the
CC       enzymatically active phosphorylase A.
CC   -!- INTERACTION:
CC       O15121:DEGS1; NbExp=1; IntAct=EBI-357469, EBI-1052713;
CC       Q9UKS6:PACSIN3; NbExp=1; IntAct=EBI-357469, EBI-77926;
CC       Q9BT40:SKIP; NbExp=1; IntAct=EBI-357469, EBI-749162;
CC   -!- PTM: Phosphorylation of Ser-15 converts phosphorylase B
CC       (unphosphorylated) to phosphorylase A.
CC   -!- DISEASE: Defects in PYGM are the cause of glycogen storage disease
CC       type 5 (GSD5) [MIM:232600]; also known as McArdle disease. GSD5 is
CC       a metabolic disorder resulting in myopathy characterized by
CC       exercise intolerance, cramps, muscle weakness and recurrent
CC       myoglobinuria.
CC   -!- SIMILARITY: Belongs to the glycogen phosphorylase family.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.genetests.org/query?gene=PYGM";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M32598; AAA60231.1; -; Genomic_DNA.
DR   EMBL; M32579; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32580; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32581; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32582; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32583; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32584; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32585; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32586; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32587; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32588; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32589; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32590; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32591; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32592; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32593; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32594; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32595; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32596; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; M32597; AAA60231.1; JOINED; Genomic_DNA.
DR   EMBL; U94777; AAC52081.1; -; Genomic_DNA.
DR   EMBL; U94774; AAC52081.1; JOINED; Genomic_DNA.
DR   EMBL; U94775; AAC52081.1; JOINED; Genomic_DNA.
DR   EMBL; U94776; AAC52081.1; JOINED; Genomic_DNA.
DR   EMBL; AF066859; AAC17451.1; -; mRNA.
DR   EMBL; BC126392; AAI26393.1; -; mRNA.
DR   EMBL; BC130514; AAI30515.1; -; mRNA.
DR   EMBL; X03031; CAA26834.1; -; mRNA.
DR   EMBL; M16013; AAA36216.1; -; mRNA.
DR   PIR; A27335; A27335.
DR   RefSeq; NP_005600.1; -.
DR   UniGene; Hs.154084; -.
DR   PDB; 1Z8D; X-ray; 2.30 A; A=1-842.
DR   PDBsum; 1Z8D; -.
DR   IntAct; P11217; -.
DR   PhosphoSite; P11217; -.
DR   Ensembl; ENSG00000068976; Homo sapiens.
DR   GeneID; 5837; -.
DR   KEGG; hsa:5837; -.
DR   NMPDR; fig|9606.3.peg.5961; -.
DR   H-InvDB; HIX0009769; -.
DR   HGNC; HGNC:9726; PYGM.
DR   MIM; 232600; phenotype.
DR   MIM; 608455; gene.
DR   Orphanet; 368; Glycogen storage disease type 5.
DR   PharmGKB; PA34069; -.
DR   HOGENOM; P11217; -.
DR   HOVERGEN; P11217; -.
DR   Reactome; REACT_1709; Metabolism of small molecules.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   ArrayExpress; P11217; -.
DR   CleanEx; HS_PYGM; -.
DR   GermOnline; ENSG00000068976; Homo sapiens.
DR   GO; GO:0008184; F:glycogen phosphorylase activity; TAS:ProtInc.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0005977; P:glycogen metabolic process; TAS:ProtInc.
DR   InterPro; IPR011833; Glycg_phsphrylas.
DR   InterPro; IPR000811; Glyco_trans_35.
DR   PANTHER; PTHR11468; Glyco_trans_35; 1.
DR   Pfam; PF00343; Phosphorylase; 1.
DR   PIRSF; PIRSF000460; Pprylas_GlgP; 1.
DR   TIGRFAMs; TIGR02093; P_ylase; 1.
DR   PROSITE; PS00102; PHOSPHORYLASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; Carbohydrate metabolism;
KW   Disease mutation; Glycogen metabolism; Glycogen storage disease;
KW   Glycosyltransferase; Nucleotide-binding; Phosphoprotein;
KW   Pyridoxal phosphate; Transferase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    842       Glycogen phosphorylase, muscle form.
FT                                /FTId=PRO_0000188529.
FT   BINDING      76     76       AMP (By similarity).
FT   BINDING     681    681       Pyridoxal phosphate (covalent) (By
FT                                similarity).
FT   SITE        109    109       Involved in the association of subunits
FT                                (By similarity).
FT   SITE        143    143       Involved in the association of subunits
FT                                (By similarity).
FT   SITE        156    156       May be involved in allosteric control (By
FT                                similarity).
FT   MOD_RES       2      2       N-acetylserine (By similarity).
FT   MOD_RES      15     15       Phosphoserine; by PHK; in form
FT                                phosphorylase A.
FT   MOD_RES     473    473       Phosphotyrosine (By similarity).
FT   VARIANT     116    116       L -> P (in GSD5).
FT                                /FTId=VAR_014002.
FT   VARIANT     194    194       R -> W (in GSD5).
FT                                /FTId=VAR_014003.
FT   VARIANT     205    205       G -> S (in GSD5).
FT                                /FTId=VAR_003431.
FT   VARIANT     292    292       L -> P (in GSD5; rare mutation).
FT                                /FTId=VAR_014004.
FT   VARIANT     349    349       E -> K (in GSD5).
FT                                /FTId=VAR_014005.
FT   VARIANT     397    397       L -> P (in GSD5).
FT                                /FTId=VAR_003432.
FT   VARIANT     488    488       T -> N (in GSD5).
FT                                /FTId=VAR_014006.
FT   VARIANT     543    543       K -> T (in GSD5).
FT                                /FTId=VAR_003433.
FT   VARIANT     602    602       R -> W (in GSD5).
FT                                /FTId=VAR_014007.
FT   VARIANT     655    655       E -> K (in GSD5).
FT                                /FTId=VAR_003434.
FT   VARIANT     660    660       A -> D (in GSD5).
FT                                /FTId=VAR_014008.
FT   VARIANT     666    666       Q -> E (in GSD5).
FT                                /FTId=VAR_014009.
FT   VARIANT     685    685       N -> Y (in GSD5).
FT                                /FTId=VAR_014010.
FT   VARIANT     686    686       G -> R (in GSD5).
FT                                /FTId=VAR_014011.
FT   VARIANT     687    687       A -> P (in GSD5).
FT                                /FTId=VAR_014012.
FT   VARIANT     704    704       A -> V (in GSD5).
FT                                /FTId=VAR_014013.
FT   VARIANT     709    709       Missing (in GSD5; common in Japanese
FT                                patients).
FT                                /FTId=VAR_014014.
FT   VARIANT     798    798       W -> R (in GSD5).
FT                                /FTId=VAR_014015.
FT   CONFLICT    791    791       L -> W (in Ref. 1; AAA60231).
FT   HELIX         7     10
FT   HELIX        11     13
FT   HELIX        25     38
FT   TURN         44     46
FT   HELIX        49     78
FT   STRAND       82     86
FT   HELIX        96    102
FT   HELIX       106    114
FT   TURN        115    117
FT   HELIX       120    126
FT   HELIX       136    150
FT   STRAND      155    160
FT   STRAND      168    172
FT   STRAND      175    179
FT   TURN        183    186
FT   HELIX       195    197
FT   STRAND      199    204
FT   STRAND      206    210
FT   STRAND      213    218
FT   STRAND      220    232
FT   STRAND      234    236
FT   STRAND      239    248
FT   HELIX       263    270
FT   HELIX       271    277
FT   HELIX       291    313
FT   HELIX       330    333
FT   STRAND      334    341
FT   TURN        342    345
FT   HELIX       346    356
FT   HELIX       362    372
FT   STRAND      373    376
FT   HELIX       382    384
FT   STRAND      387    389
FT   HELIX       390    396
FT   HELIX       398    418
FT   HELIX       423    429
FT   STRAND      431    433
FT   STRAND      435    437
FT   STRAND      439    441
FT   HELIX       442    448
FT   STRAND      451    457
FT   HELIX       458    466
FT   TURN        467    469
FT   HELIX       470    475
FT   HELIX       477    479
FT   STRAND      480    482
FT   HELIX       490    495
FT   HELIX       498    508
FT   HELIX       511    514
FT   HELIX       516    525
FT   HELIX       529    553
FT   STRAND      562    569
FT   TURN        573    576
FT   HELIX       577    593
FT   STRAND      602    607
FT   HELIX       615    631
FT   TURN        635    637
FT   HELIX       638    640
FT   STRAND      641    646
FT   HELIX       651    657
FT   HELIX       658    660
FT   STRAND      662    666
FT   TURN        670    672
FT   HELIX       678    684
FT   STRAND      688    691
FT   HELIX       697    704
FT   HELIX       706    708
FT   STRAND      709    711
FT   HELIX       716    725
FT   HELIX       730    733
FT   HELIX       737    748
FT   TURN        749    751
FT   TURN        756    759
FT   HELIX       760    768
FT   HELIX       774    792
FT   HELIX       795    806
FT   HELIX       810    812
FT   HELIX       814    824
SQ   SEQUENCE   842 AA;  97092 MW;  EBDB7D80D740B68F CRC64;
     MSRPLSDQEK RKQISVRGLA GVENVTELKK NFNRHLHFTL VKDRNVATPR DYYFALAHTV
     RDHLVGRWIR TQQHYYEKDP KRIYYLSLEF YMGRTLQNTM VNLALENACD EATYQLGLDM
     EELEEIEEDA GLGNGGLGRL AACFLDSMAT LGLAAYGYGI RYEFGIFNQK ISGGWQMEEA
     DDWLRYGNPW EKARPEFTLP VHFYGHVEHT SQGAKWVDTQ VVLAMPYDTP VPGYRNNVVN
     TMRLWSAKAP NDFNLKDFNV GGYIQAVLDR NLAENISRVL YPNDNFFEGK ELRLKQEYFV
     VAATLQDIIR RFKSSKFGCR DPVRTNFDAF PDKVAIQLND THPSLAIPEL MRILVDLERM
     DWDKAWDVTV RTCAYTNHTV LPEALERWPV HLLETLLPRH LQIIYEINQR FLNRVAAAFP
     GDVDRLRRMS LVEEGAVKRI NMAHLCIAGS HAVNGVARIH SEILKKTIFK DFYELEPHKF
     QNKTNGITPR RWLVLCNPGL AEVIAERIGE DFISDLDQLR KLLSFVDDEA FIRDVAKVKQ
     ENKLKFAAYL EREYKVHINP NSLFDIQVKR IHEYKRQLLN CLHVITLYNR IKREPNKFFV
     PRTVMIGGKA APGYHMAKMI IRLVTAIGDV VNHDPAVGDR LRVIFLENYR VSLAEKVIPA
     ADLSEQISTA GTEASGTGNM KFMLNGALTI GTMDGANVEM AEEAGEENFF IFGMRVEDVD
     KLDQRGYNAQ EYYDRIPELR QVIEQLSSGF FSPKQPDLFK DIVNMLMHHD RFKVFADYED
     YIKCQEKVSA LYKNPREWTR MVIRNIATSG KFSSDRTIAQ YAREIWGVEP SRQRLPAPDE
     AI
//
ID   CATA_BOVIN              Reviewed;         527 AA.
AC   P00432; Q3SZ80;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-JUN-2008, entry version 74.
DE   Catalase (EC 1.11.1.6).
GN   Name=CAT;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Rumen reticulum;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   PROTEIN SEQUENCE OF 2-507.
RC   TISSUE=Liver;
RX   MEDLINE=82205125; PubMed=7082009; DOI=10.1016/0003-9861(82)90044-3;
RA   Schroeder W.A., Shelton J.R., Shelton J.B., Robberson B., Apell G.,
RA   Fang R.S., Bonaventura J.;
RT   "The complete amino acid sequence of bovine liver catalase and the
RT   partial sequence of bovine erythrocyte catalase.";
RL   Arch. Biochem. Biophys. 214:397-421(1982).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RC   TISSUE=Liver;
RX   MEDLINE=82122604; PubMed=7328661; DOI=10.1016/0022-2836(81)90254-0;
RA   Murthy M.R.N., Reid T.J. III, Sicignano A., Tanaka N., Rossmann M.G.;
RT   "Structure of beef liver catalase.";
RL   J. Mol. Biol. 152:465-499(1981).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RC   TISSUE=Liver;
RA   Fita I., Silva A.M., Murthy M.R.N., Rossmann M.G.;
RT   "The refined structure of beef liver catalase at 2.5-A resolution.";
RL   Acta Crystallogr. B 42:497-515(1986).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RC   TISSUE=Liver;
RX   MEDLINE=99348592; PubMed=10417406; DOI=10.1107/S0907444999007052;
RA   Ko T.P., Day J., Malkin A.J., McPherson A.;
RT   "Structure of orthorhombic crystals of beef liver catalase.";
RL   Acta Crystallogr. D 55:1383-1394(1999).
RN   [6]
RP   SIMILARITY TO P.VITALE CATALASE.
RX   MEDLINE=86227501; PubMed=3712444; DOI=10.1016/0022-2836(86)90480-8;
RA   Melik-Adamyan W.R., Barynin V.V., Vagin A.A., Borisov V.V.,
RA   Vainshtein B.K., Fita I., Murthy M.R.N., Rossmann M.G.;
RT   "Comparison of beef liver and Penicillium vitale catalases.";
RL   J. Mol. Biol. 188:63-72(1986).
CC   -!- FUNCTION: Occurs in almost all aerobically respiring organisms and
CC       serves to protect cells from the toxic effects of hydrogen
CC       peroxide.
CC   -!- CATALYTIC ACTIVITY: 2 H(2)O(2) = O(2) + 2 H(2)O.
CC   -!- COFACTOR: Heme group.
CC   -!- COFACTOR: NADP.
CC   -!- SUBUNIT: Homotetramer.
CC   -!- SUBCELLULAR LOCATION: Peroxisome.
CC   -!- SIMILARITY: Belongs to the catalase family.
CC   -!- WEB RESOURCE: Name=Worthington enzyme manual;
CC       URL="http://www.worthington-biochem.com/CTL/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC103066; AAI03067.1; -; mRNA.
DR   PIR; A00500; CSBO.
DR   RefSeq; NP_001030463.1; -.
DR   UniGene; Bt.48925; -.
DR   PDB; 1TGU; X-ray; 2.80 A; A/B/C/D=1-507.
DR   PDB; 1TH2; X-ray; 2.80 A; A/B/C/D=1-507.
DR   PDB; 1TH3; X-ray; 2.80 A; A/B/C/D=1-507.
DR   PDB; 1TH4; X-ray; 2.98 A; A/B/C/D=1-507.
DR   PDB; 4BLC; X-ray; 2.30 A; A/B/C/D=1-507.
DR   PDB; 8CAT; X-ray; 2.50 A; A/B=1-507.
DR   PDBsum; 1TGU; -.
DR   PDBsum; 1TH2; -.
DR   PDBsum; 1TH3; -.
DR   PDBsum; 1TH4; -.
DR   PDBsum; 4BLC; -.
DR   PDBsum; 8CAT; -.
DR   PeroxiBase; 5281; BtKat01.
DR   Ensembl; ENSBTAG00000020980; Bos taurus.
DR   GeneID; 531682; -.
DR   KEGG; bta:531682; -.
DR   HOVERGEN; P00432; -.
DR   LinkHub; P00432; -.
DR   InterPro; IPR002226; Catalase.
DR   InterPro; IPR011614; Catalase_N.
DR   Gene3D; G3DSA:2.40.180.10; Catalase_N; 1.
DR   PANTHER; PTHR11465; Catalase; 1.
DR   Pfam; PF00199; Catalase; 1.
DR   PRINTS; PR00067; CATALASE.
DR   ProDom; PD000510; Catalase; 1.
DR   PROSITE; PS00437; CATALASE_1; 1.
DR   PROSITE; PS00438; CATALASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Heme; Hydrogen peroxide;
KW   Iron; Metal-binding; NADP; Oxidoreductase; Peroxidase; Peroxisome;
KW   Phosphoprotein.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    527       Catalase.
FT                                /FTId=PRO_0000084898.
FT   ACT_SITE     75     75
FT   ACT_SITE    148    148
FT   METAL       358    358       Iron (heme axial ligand).
FT   MOD_RES       2      2       Blocked amino end (Ala).
FT   MOD_RES     517    517       Phosphoserine (By similarity).
FT   CONFLICT    213    213       N -> D (in Ref. 2; AA sequence).
FT   CONFLICT    226    226       N -> D (in Ref. 2; AA sequence).
FT   TURN          7     10
FT   HELIX        11     18
FT   STRAND       43     45
FT   HELIX        55     64
FT   STRAND       73     75
FT   STRAND       77     87
FT   TURN         92     94
FT   TURN         98    100
FT   STRAND      106    114
FT   STRAND      124    128
FT   STRAND      131    138
FT   STRAND      141    152
FT   TURN        158    160
FT   HELIX       161    168
FT   TURN        172    174
FT   HELIX       179    188
FT   HELIX       190    192
FT   HELIX       193    199
FT   HELIX       202    204
FT   STRAND      205    209
FT   STRAND      220    223
FT   STRAND      229    238
FT   HELIX       247    256
FT   HELIX       260    270
FT   STRAND      276    284
FT   HELIX       286    290
FT   TURN        305    307
FT   STRAND      310    320
FT   HELIX       325    328
FT   TURN        329    331
FT   HELIX       349    365
FT   HELIX       370    372
FT   HELIX       374    376
FT   TURN        395    400
FT   STRAND      404    406
FT   HELIX       416    418
FT   STRAND      424    431
FT   STRAND      435    437
FT   HELIX       441    448
FT   HELIX       453    467
FT   HELIX       472    485
FT   HELIX       487    500
SQ   SEQUENCE   527 AA;  59915 MW;  2F97E793153D7AF9 CRC64;
     MADNRDPASD QMKHWKEQRA AQKPDVLTTG GGNPVGDKLN SLTVGPRGPL LVQDVVFTDE
     MAHFDRERIP ERVVHAKGAG AFGYFEVTHD ITRYSKAKVF EHIGKRTPIA VRFSTVAGES
     GSADTVRDPR GFAVKFYTED GNWDLVGNNT PIFFIRDALL FPSFIHSQKR NPQTHLKDPD
     MVWDFWSLRP ESLHQVSFLF SDRGIPDGHR HMNGYGSHTF KLVNANGEAV YCKFHYKTDQ
     GIKNLSVEDA ARLAHEDPDY GLRDLFNAIA TGNYPSWTLY IQVMTFSEAE IFPFNPFDLT
     KVWPHGDYPL IPVGKLVLNR NPVNYFAEVE QLAFDPSNMP PGIEPSPDKM LQGRLFAYPD
     THRHRLGPNY LQIPVNCPYR ARVANYQRDG PMCMMDNQGG APNYYPNSFS APEHQPSALE
     HRTHFSGDVQ RFNSANDDNV TQVRTFYLKV LNEEQRKRLC ENIAGHLKDA QLFIQKKAVK
     NFSDVHPEYG SRIQALLDKY NEEKPKNAVH TYVQHGSHLS AREKANL
//
ID   CASB_BOVIN              Reviewed;         224 AA.
AC   P02666; A1YQZ8; A6N8V0; Q2TA13; Q5EEQ6; Q5EEQ7; Q6UN63; Q9BDG5;
AC   Q9TSD5;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 2.
DT   01-JUL-2008, entry version 85.
DE   Beta-casein precursor [Contains: Casoparan; Antioxidant peptide;
DE   Casohypotensin].
GN   Name=CSN2;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS LEU-108; PRO-152 AND LEU-153.
RX   MEDLINE=87128158; PubMed=3814153; DOI=10.1016/0006-291X(87)90318-4;
RA   Jimenez-Flores R., Kang Y.C., Richardson T.;
RT   "Cloning and sequence analysis of bovine beta-casein cDNA.";
RL   Biochem. Biophys. Res. Commun. 142:617-621(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT HIS-82.
RA   Baev A.A., Smirnov I.K., Gorodetsky S.I.;
RT   "Primary structure of bovine beta-casein cDNA.";
RL   Mol. Biol. (Mosk.) 21:214-222(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=88188989; PubMed=2833669;
RA   Stewart A.F., Bonsing J., Beattie C.W., Shah F., Willis I.M.,
RA   Mackinlay A.G.;
RT   "Complete nucleotide sequences of bovine alpha S2- and beta-casein
RT   cDNAs: comparisons with related sequences in other species.";
RL   Mol. Biol. Evol. 4:231-241(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-82.
RX   MEDLINE=90147279; PubMed=3271384;
RA   Bonsing J., Ring J.M., Stewart A.F., Mackinlay A.G.;
RT   "Complete nucleotide sequence of the bovine beta-casein gene.";
RL   Aust. J. Biol. Sci. 41:527-537(1988).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT A3 GLN-121.
RC   TISSUE=Mammary gland;
RX   MEDLINE=94068382; PubMed=8248100; DOI=10.1093/protein/6.7.763;
RA   Simons G., van den Heuvel W., Reynen T., Frijters A., Rutten G.,
RA   Slangen C.J., Groenen M., de Vos W.M., Siezen R.J.;
RT   "Overproduction of bovine beta-casein in Escherichia coli and
RT   engineering of its main chymosin cleavage site.";
RL   Protein Eng. 6:763-770(1993).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS HIS-82 AND
RP   ARG-137.
RC   STRAIN=Crossbred X Angus; TISSUE=Liver;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-101.
RC   TISSUE=Mammary epithelium;
RX   PubMed=16624358; DOI=10.1016/j.rvsc.2006.02.002;
RA   Anaya-Lopez J.L., Contreras-Guzman O.E., Carabez-Trejo A.,
RA   Baizabal-Aguirre V.M., Lopez-Meza J.E., Valdez-Alarcon J.J.,
RA   Ochoa-Zarzosa A.;
RT   "Invasive potential of bacterial isolates associated with subclinical
RT   bovine mastitis.";
RL   Res. Vet. Sci. 81:358-361(2006).
RN   [8]
RP   PROTEIN SEQUENCE OF 16-224 (VARIANT A2), AND VARIANT LEU-108.
RX   MEDLINE=72233212; PubMed=4557764;
RA   Ribadeau-Dumas B., Brignon G., Grosclaude F., Mercier J.-C.;
RT   "Primary structure of bovine beta casein. Complete sequence.";
RL   Eur. J. Biochem. 25:505-514(1972).
RN   [9]
RP   PROTEIN SEQUENCE OF 16-224 (VARIANT A2).
RX   MEDLINE=88152252; PubMed=3278933; DOI=10.1016/0014-5793(88)81138-4;
RA   Carles C., Huet J.-C., Ribadeau-Dumas B.;
RT   "A new strategy for primary structure determination of proteins:
RT   application to bovine beta-casein.";
RL   FEBS Lett. 229:265-272(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 18-57, PROTEIN SEQUENCE OF 16-224
RP   (VARIANT H), AND VARIANT D LYS-33.
RC   STRAIN=Korean; TISSUE=Milk;
RX   MEDLINE=20154951; PubMed=10690361;
RA   Han S.K., Shin Y.C., Byun H.D.;
RT   "Biochemical, molecular and physiological characterization of a new
RT   beta-casein variant detected in Korean cattle.";
RL   Anim. Genet. 31:49-51(2000).
RN   [11]
RP   PROTEIN SEQUENCE OF 41-71; 113-157 AND 180-224, AND VARIANT GLN-132.
RX   PubMed=1804413; DOI=10.1002/rcm.1290050410;
RA   Jones D.S., Heerma W., van Wassenaar P.D., Haverkamp J.;
RT   "Analysis of bovine beta-casein tryptic digest by continuous-flow
RT   fast-atom bombardment mass spectrometry.";
RL   Rapid Commun. Mass Spectrom. 5:192-195(1991).
RN   [12]
RP   PROTEIN SEQUENCE OF 41-45, AND FUNCTION.
RX   PubMed=15545057; DOI=10.1080/09629350400003068;
RA   Lebrun I., Cavallaro V., Juliano L., Juliano M.A.,
RA   de Sousa e Silva M.C.C.;
RT   "Effects of 'casoparan', a peptide isolated from casein hydrolysates
RT   with mastoparan-like properties.";
RL   Mediators Inflamm. 13:263-268(2004).
RN   [13]
RP   PROTEIN SEQUENCE OF 48-63, AND VARIANT E LYS-51.
RX   MEDLINE=75005247; PubMed=4411121; DOI=10.1016/0014-5793(74)80796-9;
RA   Grosclaude F., Mahe M.-F., Voglino G.-F.;
RT   "The beta E variant and the phosphorylation code of bovine caseins.";
RL   FEBS Lett. 45:3-5(1974).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 58-223.
RA   Otaviano A.R., Lima A.L.F., Laureano M.M.M., Albuquerque L.G.,
RA   Tonhati H., Sena J.A.D.;
RT   "Polymorphisms in beta and kappa casein genes in bubaline and
RT   bovine.";
RL   Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 58-223.
RA   Shahla M.N., Cheema F.R., Naeem M.K., Riazuddin S.;
RT   "Polymorphism in the cattle beta casein gene.";
RL   Submitted (MAY-2007) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 63-208.
RC   TISSUE=Mammary gland;
RA   Klotz A., Buchberger J., Krause I., Einspanier R.;
RT   "Characterization of milk proteins.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 68-105.
RX   MEDLINE=85155504; PubMed=6397405; DOI=10.1016/0378-1119(84)90013-1;
RA   Ivanov V.N., Kershulite D.R., Bayev A.A., Akhundova A.A.,
RA   Sulimova G.E., Judinkova E.S., Gorodetsky S.I.;
RT   "Identification of bacterial clones encoding bovine caseins by direct
RT   immunological screening of the cDNA library.";
RL   Gene 32:381-388(1984).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 68-95.
RX   MEDLINE=86014005; PubMed=3900695;
RA   Ivanov V.N., Kershulite D.R., Bayev A.A., Akhundova A.A.,
RA   Silimova G.E.;
RT   "Identification of bacterial clones that encode cow's caseins by
RT   direct immunological screening of the cDNA library.";
RL   Mol. Biol. (Mosk.) 19:955-963(1985).
RN   [19]
RP   PROTEIN SEQUENCE OF 74-108, VARIANT LEU-108, PHOSPHORYLATION, AND MASS
RP   SPECTROMETRY.
RX   PubMed=17720176; DOI=10.1016/j.chroma.2007.08.015;
RA   Schmelzer C.E.H., Schoeps R., Reynell L., Ulbrich-Hofmann R.,
RA   Neubert R.H.H., Raith K.;
RT   "Peptic digestion of beta-casein: Time course and fate of possible
RT   bioactive peptides.";
RL   J. Chromatogr. A 1166:108-115(2007).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 80-143, AND VARIANT LEU-108.
RA   Jann O., Ceriotti G., Caroli A., Erhardt G.;
RT   "A new variant in exon VII of bovine beta-casein gene (CSN2) and its
RT   contribution among European cattle breeds.";
RL   J. Anim. Breed. Genet. 119:65-68(2002).
RN   [21]
RP   PROTEIN SEQUENCE OF 113-120, FUNCTION, AND MASS SPECTROMETRY.
RA   Gupta A., Mann B., Kumar Bajaj R., Sangwan R.B.;
RT   "Studies on antioxidative peptides generated in cheddar cheese.";
RL   Submitted (JAN-2008) to UniProtKB.
RN   [22]
RP   PROTEIN SEQUENCE OF 118-124, AND VARIANT A3 GLN-121.
RX   MEDLINE=71252171; PubMed=4997616;
RA   Ribadeau-Dumas B., Grosclaude F., Mercier J.-C.;
RT   "Localization in the peptide chain of bovine beta casein of the His-
RT   Gln substitution differentiating the A2 and A3 genetic variants.";
RL   C.R. Hebd. Seances Acad. Sci., D, Sci. Nat. 270:2369-2372(1970).
RN   [23]
RP   PROTEIN SEQUENCE OF 125-195 (VARIANTS A1 AND G).
RX   AGRICOLA=IND22004684; DOI=10.1016/S0958-6946(99)00019-9;
RA   Dong C., Ng-Kwai-Hang K.F.;
RT   "Characterization of a non-electrophoretic genetic variant of beta-
RT   casein by peptide mapping and mass spectrometric analysis.";
RL   Int. Dairy J. 8:967-972(1998).
RN   [24]
RP   PROTEIN SQUENCE OF 129-136, FUNCTION, AND VARIANT GLN-132.
RX   PubMed=7600458;
RA   Lebrun I., Lebrun F.L.A.S., Henriques O.B., Carmona A.K., Juliano L.,
RA   Camargo A.C.M.;
RT   "Isolation and characterization of a new bradykinin potentiating
RT   octapeptide from gamma-casein.";
RL   Can. J. Physiol. Pharmacol. 73:85-91(1995).
RN   [25]
RP   PROTEIN SQUENCE OF 129-136, AND FUNCTION.
RX   PubMed=14714726; DOI=10.1023/B:JOPC.0000008724.98339.ff;
RA   Perpetuo E.A., Juliano L., Lebrun I.;
RT   "Biochemical and pharmacological aspects of two bradykinin-
RT   potentiating peptides obtained from tryptic hydrolysis of casein.";
RL   J. Protein Chem. 22:601-606(2003).
RN   [26]
RP   PROTEIN SEQUENCE OF 160-171 (VARIANT F).
RX   MEDLINE=96118672; PubMed=7496485; DOI=10.1016/0021-9673(95)00058-U;
RA   Visser S., Slangen C.J., Lagerwerf F.M., Van Dongen W.D.,
RA   Haverkamp J.;
RT   "Identification of a new genetic variant of bovine beta-casein using
RT   reversed-phase high-performance liquid chromatography and mass
RT   spectrometric analysis.";
RL   J. Chromatogr. A 711:141-150(1995).
RN   [27]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 170-184.
RX   MEDLINE=83182023; PubMed=6897774;
RA   Willis I.M., Stewart A.F., Caputo A., Thompson A.R., McKinlay A.G.;
RT   "Construction and identification by partial nucleotide sequence
RT   analysis of bovine casein and beta-lactoglobulin cDNA clones.";
RL   DNA 1:375-386(1982).
RN   [28]
RP   PHOSPHORYLATION AT SER-30; SER-32; SER-33; SER-34 AND SER-50, AND MASS
RP   SPECTROMETRY.
RX   PubMed=16083266; DOI=10.1021/pr050113n;
RA   Wu S.L., Kim J., Hancock W.S., Karger B.;
RT   "Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS
RT   platform for high sequence coverage of complex proteins with extensive
RT   post-translational modifications-comprehensive analysis of beta-casein
RT   and epidermal growth factor receptor (EGFR).";
RL   J. Proteome Res. 4:1155-1170(2005).
RN   [29]
RP   PHOSPHORYLATION AT SER-30; SER-32; SER-33; SER-34 AND SER-50, AND MASS
RP   SPECTROMETRY.
RX   PubMed=17510049; DOI=10.1074/mcp.M600480-MCP200;
RA   Imanishi S.Y., Kochin V., Ferraris S.E., de Thonel A., Pallari H.M.,
RA   Corthals G.L., Eriksson J.E.;
RT   "Reference-facilitated phosphoproteomics: fast and reliable
RT   phosphopeptide validation by micro LC-ESI-Q-TOF MS/MS.";
RL   Mol. Cell. Proteomics 6:1380-1391(2007).
RN   [30]
RP   VARIANTS A1; B AND C.
RX   MEDLINE=72214259; PubMed=5064450;
RA   Grosclaude F., Mahe M.-F., Mercier J.-C., Ribadeau-Dumas B.;
RT   "Characterization of genetic variants of alpha-S1 and beta bovine
RT   caseins.";
RL   Eur. J. Biochem. 26:328-337(1972).
CC   -!- FUNCTION: Important role in determination of the surface
CC       properties of the casein micelles.
CC   -!- FUNCTION: Casoparan acts as a macrophage activator, increasing the
CC       phagocytic activity of macrophages and peroxide release from
CC       macrophages. It also acts as a bradykinin-potentiating peptide.
CC   -!- FUNCTION: Casohypotensin acts as a bradykinin-potentiating
CC       peptide. Induces hypotension in rats. Acts as a strong competitive
CC       inhibitor of endo-oligopeptidase A.
CC   -!- FUNCTION: Antioxidant peptide has antioxidant activity.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Mammary gland specific. Secreted in milk.
CC   -!- MASS SPECTROMETRY: Mass=872.51; Method=Electrospray; Range=113-
CC       120; Source=Ref.21;
CC   -!- POLYMORPHISM: Leu-152 is present in the variants F and G; Gln-190
CC       and Glu-210 are present in the variant H. The sequence shown is
CC       the A2 variant.
CC   -!- SIMILARITY: Belongs to the beta-casein family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ABL74247.1; Type=Frameshift; Positions=65, 71;
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Of buttons, digestion
CC       and glue - Issue 16 of November 2001;
CC       URL="http://www.expasy.org/spotlight/back_issues/sptlt016.shtml";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M15132; AAA30430.1; -; mRNA.
DR   EMBL; X06359; CAA29658.1; -; mRNA.
DR   EMBL; M16645; AAA30480.1; -; mRNA.
DR   EMBL; M55158; AAA30431.1; -; Genomic_DNA.
DR   EMBL; S67277; AAB29137.1; -; mRNA.
DR   EMBL; BC111172; AAI11173.1; -; mRNA.
DR   EMBL; AY899917; AAW84270.1; ALT_INIT; mRNA.
DR   EMBL; AY899918; AAW84271.1; ALT_INIT; mRNA.
DR   EMBL; AF104929; AAD09813.1; -; Genomic_DNA.
DR   EMBL; AF104928; AAD09813.1; JOINED; Genomic_DNA.
DR   EMBL; EF123100; ABL74247.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; EF628290; ABR10906.1; -; Genomic_DNA.
DR   EMBL; AJ296330; CAC37028.1; -; Genomic_DNA.
DR   EMBL; M64756; AAB59254.1; -; mRNA.
DR   EMBL; AY366419; AAR14677.1; -; Genomic_DNA.
DR   EMBL; K01087; AAA30481.1; -; mRNA.
DR   PIR; A59068; A59068.
DR   PIR; I45873; KBBOA2.
DR   RefSeq; NP_851351.1; -.
DR   UniGene; Bt.49421; -.
DR   UniGene; Bt.53272; -.
DR   DisProt; DP00329; -.
DR   Ensembl; ENSBTAG00000002632; Bos taurus.
DR   GeneID; 281099; -.
DR   KEGG; bta:281099; -.
DR   HOVERGEN; P02666; -.
DR   InterPro; IPR001588; Casein.
DR   InterPro; IPR016345; Casein_beta.
DR   Pfam; PF00363; Casein; 1.
DR   PIRSF; PIRSF002372; Beta-casein; 1.
DR   PROSITE; PS00306; CASEIN_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   Antioxidant; Direct protein sequencing; Hypotensive agent;
KW   Metalloenzyme inhibitor; Metalloprotease inhibitor; Milk protein;
KW   Phosphoprotein; Polymorphism; Secreted; Signal.
FT   SIGNAL        1     15
FT   CHAIN        16    224       Beta-casein.
FT                                /FTId=PRO_0000004470.
FT   PEPTIDE      41     45       Casoparan.
FT                                /FTId=PRO_0000292031.
FT   PEPTIDE     113    120       Antioxidant peptide.
FT                                /FTId=PRO_0000320153.
FT   PEPTIDE     129    136       Casohypotensin.
FT                                /FTId=PRO_0000308464.
FT   MOD_RES      30     30       Phosphoserine.
FT   MOD_RES      32     32       Phosphoserine.
FT   MOD_RES      33     33       Phosphoserine.
FT   MOD_RES      34     34       Phosphoserine.
FT   MOD_RES      50     50       Phosphoserine; in variant A1, variant A2,
FT                                variant A3, variant B, variant E, variant
FT                                F, variant G and variant H.
FT   VARIANT      33     33       S -> K (in variant D).
FT   VARIANT      40     40       R -> C (in variant H).
FT   VARIANT      51     51       E -> K (in variant E).
FT   VARIANT      52     52       E -> K (in variant C).
FT   VARIANT      82     82       P -> H (in variants A1, B, C, F and G).
FT   VARIANT     103    103       L -> I (in variant H).
FT   VARIANT     108    108       M -> L.
FT   VARIANT     121    121       H -> Q (in variant A3).
FT   VARIANT     132    132       E -> Q (in variants A1 and G).
FT   VARIANT     137    137       S -> R (in variant B).
FT   VARIANT     152    152       L -> P (in variants A1 and H).
FT   VARIANT     153    153       P -> L (in variants A1, G and H).
FT   VARIANT     167    167       P -> L (in variant F).
FT   VARIANT     190    190       Q -> E (in variants A1 and G).
FT   CONFLICT     50     50       S -> Z (in Ref. 11; AA sequence).
FT   CONFLICT     69     69       Q -> R (in Ref. 14; ABL74247).
FT   CONFLICT    112    112       K -> R (in Ref. 14; ABL74247).
FT   CONFLICT    208    208       Y -> V (in Ref. 16; CAC37028).
FT   CONFLICT    209    210       QE -> EQ (in Ref. 11; AA sequence).
FT   CONFLICT    210    210       E -> Q (in Ref. 1; AAA30430 and 8).
FT   CONFLICT    212    212       V -> A (in Ref. 15; ABR10906).
SQ   SEQUENCE   224 AA;  25107 MW;  F0BBDD8148A238AE CRC64;
     MKVLILACLV ALALARELEE LNVPGEIVES LSSSEESITR INKKIEKFQS EEQQQTEDEL
     QDKIHPFAQT QSLVYPFPGP IPNSLPQNIP PLTQTPVVVP PFLQPEVMGV SKVKEAMAPK
     HKEMPFPKYP VEPFTESQSL TLTDVENLHL PLPLLQSWMH QPHQPLPPTV MFPPQSVLSL
     SQSKVLPVPQ KAVPYPQRDM PIQAFLLYQE PVLGPVRGPF PIIV
//
ID   4EBP1_RAT               Reviewed;         117 AA.
AC   Q62622;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-JUN-2008, entry version 49.
DE   Eukaryotic translation initiation factor 4E-binding protein 1 (eIF4E-
DE   binding protein 1) (4E-BP1) (Phosphorylated heat- and acid-stable
DE   protein regulated by insulin 1) (PHAS-I).
GN   Name=Eif4ebp1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 18-33; 43-53; 62-80
RP   AND 98-117, PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Adipocyte, and Skeletal muscle;
RX   MEDLINE=94224815; PubMed=8170978;
RA   Hu C., Pang S., Kong X., Velleca M., Lawrence J.C. Jr.;
RT   "Molecular cloning and tissue distribution of PHAS-I, an intracellular
RT   target for insulin and growth factors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3730-3734(1994).
RN   [2]
RP   FUNCTION, INTERACTION WITH EIF4E, PHOSPHORYLATION AT SER-64 BY MAPK1
RP   AND MAPK3, AND MUTAGENESIS OF SER-64.
RX   MEDLINE=95025978; PubMed=7939721;
RA   Lin T.-A., Kong X., Haystead T.A.J., Pause A., Belsham G.J.,
RA   Sonenberg N., Lawrence J.C. Jr.;
RT   "PHAS-I as a link between mitogen-activated protein kinase and
RT   translation initiation.";
RL   Science 266:653-656(1994).
CC   -!- FUNCTION: Regulates eIF4E activity by preventing its assembly into
CC       the eIF4F complex. Mediates the regulation of protein translation
CC       by hormones, growth factors and other stimuli that signal through
CC       the MAP kinase pathway.
CC   -!- SUBUNIT: Nonphosphorylated EIF4EBP1 competes with EIF4G1/EIFG3 to
CC       interact with EIF4E; insulin stimulated MAP-kinase (MAPK1 and
CC       MAPK3) phosphorylation of EIF4EBP1 causes dissociation of the
CC       complex allowing EIF4G to bind and consequent initiation of
CC       translation. Rapamycin can attenuate insulin stimulation, mediated
CC       by FKBPs.
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined; highest
CC       levels in fat and skeletal tissue, lowest levels in kidney.
CC   -!- PTM: Phosphorylated upon DNA damage, probably by ATM or ATR (By
CC       similarity). Phosphorylated on serine and threonine residues in
CC       response to insulin, EGF and PDGF.
CC   -!- SIMILARITY: Belongs to the eIF4E-binding protein family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U05014; AAA86938.1; -; mRNA.
DR   PIR; A55258; A55258.
DR   RefSeq; NP_446309.1; -.
DR   UniGene; Rn.11161; -.
DR   DIP; DIP:267N; -.
DR   PhosphoSite; Q62622; -.
DR   Ensembl; ENSRNOG00000012582; Rattus norvegicus.
DR   GeneID; 116636; -.
DR   KEGG; rno:116636; -.
DR   RGD; 620259; Eif4ebp1.
DR   HOVERGEN; Q62622; -.
DR   ArrayExpress; Q62622; -.
DR   GermOnline; ENSRNOG00000012582; Rattus norvegicus.
DR   InterPro; IPR008606; EIF4EBP.
DR   PANTHER; PTHR12669; EIF4EBP; 1.
DR   Pfam; PF05456; eIF_4EBP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Direct protein sequencing; Phosphoprotein;
KW   Protein synthesis inhibitor; Translation regulation.
FT   INIT_MET      1      1       Removed (By similarity).
FT   CHAIN         2    117       Eukaryotic translation initiation factor
FT                                4E-binding protein 1.
FT                                /FTId=PRO_0000190515.
FT   MOD_RES       2      2       N-acetylserine (By similarity).
FT   MOD_RES      34     34       Phosphoserine (By similarity).
FT   MOD_RES      35     35       Phosphothreonine (By similarity).
FT   MOD_RES      36     36       Phosphothreonine (By similarity).
FT   MOD_RES      40     40       Phosphothreonine (By similarity).
FT   MOD_RES      45     45       Phosphothreonine (By similarity).
FT   MOD_RES      49     49       Phosphothreonine (By similarity).
FT   MOD_RES      64     64       Phosphoserine; by MAPK1 and MAPK3.
FT   MOD_RES      69     69       Phosphothreonine (By similarity).
FT   MOD_RES      81     81       Phosphothreonine (By similarity).
FT   MOD_RES      82     82       Phosphoserine (By similarity).
FT   MOD_RES      93     93       Phosphoserine (By similarity).
FT   MOD_RES     100    100       Phosphoserine (By similarity).
FT   MOD_RES     111    111       Phosphoserine (By similarity).
FT   MUTAGEN      64     64       S->A: Decreases phosphorylation by MAPK1
FT                                and MAPK3.
FT   CONFLICT     19     19       R -> N (in Ref. 1; AA sequence).
FT   CONFLICT     69     69       T -> P (in Ref. 1; AA sequence).
FT   CONFLICT     75     75       P -> L (in Ref. 1; AA sequence).
SQ   SEQUENCE   117 AA;  12404 MW;  3449D57B09FA101A CRC64;
     MSAGSSCSQT PSRAIPTRRV ALGDGVQLPP GDYSTTPGGT LFSTTPGGTR IIYDRKFLME
     CRNSPVAKTP PKDLPTIPGV TSPTSDEPPM QASQSHLHSS PEDKRAGGEE SQFEMDI
//
ID   1433E_HUMAN             Reviewed;         255 AA.
AC   P62258; P29360; P42655; Q53XZ5; Q63631; Q7M4R4;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   01-JUL-2008, entry version 54.
DE   14-3-3 protein epsilon (14-3-3E).
GN   Name=YWHAE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=95372385; PubMed=7644510;
RA   Conklin D.S., Galaktionov K., Beach D.;
RT   "14-3-3 proteins associate with cdc25 phosphatases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7892-7896(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   MEDLINE=97011338; PubMed=8858348;
RA   Chong S.S., Tanigami A., Roschke A.V., Ledbetter D.H.;
RT   "14-3-3 epsilon has no homology to LIS1 and lies telomeric to it on
RT   chromosome 17p13.3 outside the Miller-Dieker syndrome chromosome
RT   region.";
RL   Genome Res. 6:735-741(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=96300316; PubMed=8684458; DOI=10.1038/382308a0;
RA   Jin D.-Y., Lyu M.S., Kozak C.A., Jeang K.-T.;
RT   "Function of 14-3-3 proteins.";
RL   Nature 382:308-308(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RA   Luk S.C.W., Lee C.Y., Waye M.M.Y.;
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tanigami A., Chong S.S., Ledbetter D.H.;
RT   "14-3-3 epsilon genomic sequence.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 1-19.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [10]
RP   PROTEIN SEQUENCE OF 1-19; 30-50 AND 131-170, ACETYLATION AT MET-1, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAY-2005) to UniProtKB.
RN   [11]
RP   PROTEIN SEQUENCE OF 103-108; 120-123; 131-141 AND 143-153.
RC   TISSUE=Histiocytic lymphoma;
RX   MEDLINE=91224664; PubMed=2026444;
RA   Demeter J., Medzihradszky D., Kha H., Goetzl E.J., Turck C.W.;
RT   "Isolation and partial characterization of the structures of
RT   fibroblast activating factor-related proteins from U937 cells.";
RL   Immunology 72:350-354(1991).
RN   [12]
RP   PROTEIN SEQUENCE OF 131-141 AND 154-190, AND MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [13]
RP   INTERACTION WITH HCV CORE PROTEIN.
RX   MEDLINE=20111292; PubMed=10644344;
RX   DOI=10.1128/JVI.74.4.1736-1741.2000;
RA   Aoki H., Hayashi J., Moriyama M., Arakawa Y., Hino O.;
RT   "Hepatitis C virus core protein interacts with 14-3-3 protein and
RT   activates the kinase Raf-1.";
RL   J. Virol. 74:1736-1741(2000).
RN   [14]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathway. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner.
CC   -!- SUBUNIT: Homodimer. Interacts with NDEL1, RGNEF and TIAM2 (By
CC       similarity). Interacts with HCV core protein.
CC   -!- INTERACTION:
CC       Q9P0K1-3:ADAM22; NbExp=1; IntAct=EBI-356498, EBI-1567267;
CC       P46527:CDKN1B; NbExp=1; IntAct=EBI-356498, EBI-519280;
CC       O94921:PFTK1; NbExp=3; IntAct=EBI-356498, EBI-1043945;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Melanosome.
CC       Note=Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U20972; AAC50175.1; -; mRNA.
DR   EMBL; U54778; AAC50710.1; -; mRNA.
DR   EMBL; U43399; AAC50625.1; -; mRNA.
DR   EMBL; U43430; AAD00026.1; -; mRNA.
DR   EMBL; U28936; AAA75301.1; -; mRNA.
DR   EMBL; AB017103; BAA32538.1; -; Genomic_DNA.
DR   EMBL; BT007161; AAP35825.1; -; mRNA.
DR   EMBL; CH471108; EAW90628.1; -; Genomic_DNA.
DR   EMBL; BC000179; AAH00179.1; -; mRNA.
DR   EMBL; BC001440; AAH01440.1; -; mRNA.
DR   PIR; A61235; A61235.
DR   PIR; I38947; I38947.
DR   RefSeq; NP_006752.1; -.
DR   UniGene; Hs.513851; -.
DR   PDB; 2BR9; X-ray; 1.75 A; A=1-233.
DR   PDBsum; 2BR9; -.
DR   IntAct; P62258; -.
DR   OGP; P42655; -.
DR   PeptideAtlas; P62258; -.
DR   Ensembl; ENSG00000108953; Homo sapiens.
DR   GeneID; 7531; -.
DR   KEGG; hsa:7531; -.
DR   H-InvDB; HIX0013397; -.
DR   H-InvDB; HIX0013751; -.
DR   H-InvDB; HIX0030006; -.
DR   HGNC; HGNC:12851; YWHAE.
DR   MIM; 605066; gene.
DR   PharmGKB; PA37440; -.
DR   HOGENOM; P62258; -.
DR   HOVERGEN; P62258; -.
DR   LinkHub; P62258; -.
DR   ArrayExpress; P62258; -.
DR   CleanEx; HS_YWHAE; -.
DR   GermOnline; ENSG00000108953; Homo sapiens.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0007242; P:intracellular signaling cascade; TAS:ProtInc.
DR   InterPro; IPR000308; 14-3-3.
DR   Gene3D; G3DSA:1.20.190.20; 14-3-3; 1.
DR   PANTHER; PTHR18860; 14-3-3; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   ProDom; PD000600; 14-3-3; 1.
DR   SMART; SM00101; 14_3_3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW   Host-virus interaction; Phosphoprotein.
FT   CHAIN         1    255       14-3-3 protein epsilon.
FT                                /FTId=PRO_0000058618.
FT   MOD_RES       1      1       N-acetylmethionine.
FT   MOD_RES     210    210       Phosphoserine.
FT   CONFLICT    106    107       KH -> NY (in Ref. 11; AA sequence).
FT   CONFLICT    143    143       E -> F (in Ref. 11; AA sequence).
FT   CONFLICT    148    148       S -> T (in Ref. 11; AA sequence).
FT   HELIX         4     17
FT   HELIX        20     31
FT   HELIX        39     73
FT   HELIX        76    106
FT   HELIX       108    111
FT   HELIX       115    135
FT   HELIX       138    162
FT   HELIX       168    183
FT   HELIX       188    204
FT   HELIX       205    208
FT   TURN        211    213
FT   HELIX       214    231
SQ   SEQUENCE   255 AA;  29174 MW;  07817CCBD1F75B26 CRC64;
     MDDREDLVYQ AKLAEQAERY DEMVESMKKV AGMDVELTVE ERNLLSVAYK NVIGARRASW
     RIISSIEQKE ENKGGEDKLK MIREYRQMVE TELKLICCDI LDVLDKHLIP AANTGESKVF
     YYKMKGDYHR YLAEFATGND RKEAAENSLV AYKAASDIAM TELPPTHPIR LGLALNFSVF
     YYEILNSPDR ACRLAKAAFD DAIAELDTLS EESYKDSTLI MQLLRDNLTL WTSDMQGDGE
     EQNKEALQDV EDENQ
//
ID   PNEU_HUMAN              Reviewed;          10 AA.
AC   P22103;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   10-JUN-2008, entry version 27.
DE   Pneumadin (PNM).
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   PROTEIN SEQUENCE.
RC   TISSUE=Lung;
RX   MEDLINE=91110910; PubMed=2274681; DOI=10.1016/0167-0115(90)90049-3;
RA   Batra V.K., Mathur M., Mir S.A., Kapoor R., Kumar M.A.;
RT   "Pneumadin: a new lung peptide which triggers antidiuresis.";
RL   Regul. Pept. 30:77-87(1990).
CC   -!- FUNCTION: Antidiuretic peptide that triggers the release of ADH.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   PIR; B33143; B33143.
DR   HOVERGEN; P22103; -.
DR   GO; GO:0030103; P:vasopressin secretion; NAS:UniProtKB.
PE   1: Evidence at protein level;
KW   Amidation; Direct protein sequencing.
FT   PEPTIDE       1     10       Pneumadin.
FT                                /FTId=PRO_0000044206.
FT   MOD_RES      10     10       Valine amide.
SQ   SEQUENCE   10 AA;  956 MW;  640378DAA723276B CRC64;
     AGEPKLDAGV
//
